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 The conformational flexibility of target proteins is a major challenge in un
modeling protein-drug interactions. A fundamental issue, yet to be clarified
observed conformational changes are controlled by the protein, or induced by the inhibitor. 
that accompany ligand binding, there is growing evidence in support of th
proteins’ intrinsic dynamics, which has been evolutionarily optimized to a
functional interactions. The wealth of structural data for target proteins in 
different ligands now permits us to make a critical assessment of the balance be
reverse transcriptase, p38 MAP kinase, and cyclin-dependent kinase 2. A total of 292 structures 
determined for these enzymes in the presence of different inhibitors as well a
permitted us to perform an extensive comparative analysis of the conformationa
derstanding and 
, is whether the 
While the concept of induced fit has been widely adopted for describing the structural changes 
e dominance of 
ccommodate its 
the presence of 
tween these two 
effects in selecting the bound forms. We focused on three widely studied drug targets, HIV-1 
s unbound form 
l space accessed 
upon ligand binding, and its relation to the intrinsic dynamics prior to ligand binding as predicted 
by elastic network model analysis. Further, we analyzed NMR ensembles of ubiquitin and 
calmodulin representing their microseconds range solution dynamics. Our results show that the 
ligand selects the conformer that best matches its structural and dynamic properties amongst the 
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conformers intrinsically accessible to the protein in the unliganded form. The results suggest that 
 pre-defining the 
ning inhibitors. 
Ps), which are 
interactions and selectivity of MKP inhibitors and shows how an allosteric inhibition mechanism 
or the functional 
tructure-encoded dynamics of rhodopsin and nicotinic acetylcholine 
receptor, members of two membrane proteins classes serving as targets for more than 40% of all 
current FDA approved drugs. 
 
 
simple but robust rules encoded in the protein structure play a dominant role in
mechanisms of ligand binding, which may be advantageously exploited in desig
We apply these lessons to the study of MAP kinase phosphatases (MK
therapeutically relevant but challenging signaling enzymes. Our study provides insights into the 
holds for a recently discovered inhibitor of MKP-3. We also provide evidence f
significance of the s
 v 
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1.0  INTRODUCTION 
 
1.1 ROLE OF PROTEIN DYNAMICS IN SMALL MOLECULE RECOGNITION 
AND BINDING 
nderstanding the 
 major challenge with impact on 
drug discovery. Yet, progress in this field has been impeded by the complexity and specificity of 
interactions, the multiplicity of conformations accessible under equilibrium conditions, as well as 
of the broad range of equilibrium motions that are 
observed to accompany small-molecule ligand binding. These motions range from rotations of 
side-chains interacting with the ligand to globular motions engaging domains or subunits. The 
atomic scale details of such changes are explored using X-ray crystallography and nuclear 
magnetic resonance (NMR) spectroscopy techniques.  
 
 
The dynamic nature of proteins plays a critical role in molecular recognition. U
determinants of ligand-recognition and -binding dynamics is a
insufficient data on the structure and energetics of protein-ligand interactions.  
 
Figure 1.1 provides an overview 
 1 
 Figure 1.1 Range of equilibrium motions that accompany small-molecule ligand
Motions that accompany the binding of small molecules range from side-chain rotations to slowe
motions.  X-ray crystallography and NMR are the primary sources of information on such confor
atomic resolution. Also indicated
 binding. 
r concerted domain 
mational changes at 
 along the abscissa are the timescales of processes that can be explored by 
molecular dynamics simulations (MD) and coarse-grained (CG) computations. Figure is adapted from (Bahar et al., 
2009 ed using Chimera ). Molecular diagrams here and in the following figures have been generat
(http://www.cgl.ucsf.edu/chimera/) (Pettersen et al., 2004), VMD (Humphrey et al., 1996), or PyMol 
(http://pymol.org/) visualization software. 
 
Two different models have been proposed for explaining the conformational changes 
observed between the bound and unbound forms of proteins. The classical view, which dates 
back to the original work of Koshland in 1958, proposes an induced fit mechanism whereby 
 2 
ligand binding induces conformational changes on the target protein (Koshland, 1958). Such an 
rangements in 
triggered by the 
lexes, including 
alternate view, pioneered by Monod, Wyman, and Changeux (MWC model) (Monod et al., 
perimental and 
l., 2003; Tobi & 
chweiler, 2007; 
consistent with the accessibility of a host of conformational substates under native state 
ns (pre-existing 
and bind a particular ligand 
(conformational selection). Therefore, observed structural rearrangements would not occur if it 
wer etween multiple 
conformers including those prone to readily bind the ligand (Bahar et al., 2007).  
etween intrinsic 
ted that stronger 
and long-range interactions favor induced fit, while shorter-range interactions favor 
conformational selection (Okazaki & Takada, 2008). Even if binding occurs via conformational 
selection, additional rearrangements may be induced to stabilize the complex (James & Tawfik, 
2005; Tobi & Bahar, 2005). And while protein-protein interactions may be strongly affected by 
onset of conformational changes could be plausible on a local scale, i.e., slight rear
side chain reorientations or even transitions between isomeric states could be 
ligand. However, the more cooperative changes observed in other comp
concerted rearrangements of entire domains, have challenged this classical concept. The second, 
1965), has gained broad acceptance in the last decade, supported by ex
computational studies (Ma et al., 1999; Kern & Zuiderweg, 2003; James et a
Bahar, 2005; Mittermaier & Kay, 2006; Bahar et al., 2007; Showalter & Brus
Tang et al., 2007; Lange et al., 2008; Gsponer et al., 2008; Ivetac & McCammon, 2009). It is 
conditions. Accordingly, the protein samples an ensemble of conformatio
equilibrium), a fraction of which is predisposed to recognize 
e not for the pre-disposition or intrinsic dynamics of the protein to fluctuate b
 
A number of more recent studies suggest a more complex interplay b
dynamics and ligand-induced motions. For example, Okazaki and Takada repor
 3 
their intrinsic dynamics, it is unclear which effect, intrinsic dynamics vs. induced dynamics, 
any cases 
xample that the 
van & Holyoak, 
d in intrinsically disordered protein 
segments (Turjanski et al., 2008). 
 
1.2 COMPUTATIONAL METHODS FOR LEARNING AND MODELING PROTEIN 
DYNAMICS AND INTERACTIONS 
in in the Protein 
models for rapid 
estimation of intrinsic dynamics, we are now in a position to (i) critically examine sets of 
conformations assumed by the same protein in the presence of different ligands and (ii) compare 
se conformational changes to those predicted for the unliganded protein using simplified, 
physics-based models. While such comparisons between experimental and computational data 
may be obscured by the heterogeneities of the accessible conformations and uncertainties in 
atomic coordinates, there exist powerful methods to extract dominant patterns from complex 
data.  
 
plays a dominant role, in protein-small molecule interactions, which may entail in m
highly specific, localized interactions. Sullivan and Holyoak argued for e
presence of a lid at the binding site implies an induced fit mechanism (Sulli
2008); and folding upon binding is commonly observe
 
With the rapid accumulation of multiple liganded structures for a given prote
Data Bank (PDB) (Berman et al., 2000) and with the development of analytical 
the
 4 
With regard to experimental data, principal component analysis (PCA) is an old but 
pplication is the 
d with different 
residual dipolar 
mational changes 
assumed in different complexes, and those observed for the isolated protein in solution show 
close overlap, and essentially represent displacements along a well-defined (combined) principal 
mo
odes of 
motion is normal mode analysis (NMA) (Kitao & Go, 1999; Cui & Bahar, 2006). Normal mode 
ssuming that the 
k to early 1980s. 
ied models, such 
), can be utilized 
to efficiently predict global modes of motions (Figure 1.2). These motions are characterized by a 
high degree of collectivity, and usually lie at the lowest frequency end of the mode spectrum. 
They are insensitive to structural details or underlying force field, but defined by the overall 
architecture, or topology of inter-residue contacts in the native structure (Cui & Bahar, 2006; 
Nicolay & Sanejouand, 2006; Tama & Brooks, 2006).  
 
powerful method to unveil the principal variations in structure. An excellent a
recent examination of the ensemble of ubiquitin X-ray structures complexe
substrates, in comparison to the ensemble of NMR models determined by 
coupling measurements (Lange et al., 2008). This study showed that the confor
de of deformation intrinsically favored by the unbound protein. 
 
As to structural dynamics, again a classical approach to retrieve dominant m
analysis provides information on the equilibrium modes accessible to a system, a
system is stabilized by harmonic potentials.  Its application to proteins dates bac
In recent years, NMA has seen a revival with the realization that highly simplif
as the anisotropic network model (ANM) (Atilgan et al., 2001; Eyal et al., 2006
 5 
 Figure 1.2 Energy profile of the native state modeled at different resol
N denotes the native state, modeled at a CG scale as a single energy minimum. A detailed
structure and energetics may reveal multiple substates (S1, S2, etc.), which in turn contain multip
m2, etc.). Structural models corresponding to different hierarchical levels of resolution are shown: an elastic 
network model representation where the global energy minimum on a CG scale (N) is approxim
potential along each mode direction (e.g. anisotropic network model (ANM)); two substa
utions. 
 examination of the 
le microstates (m1, 
ated by a harmonic 
tes S1 and S2 sampled by 
glob l motions near native state conditions; and an ensemble of conformers sampled by small fluctuations in the 
neig borhood of each substate. The diagrams have been constructed using the following rhodopsin structures 
deposited in the PDB:  1U19 (N); 1U19 and 3CAP (S1 and S2) and 1F88, 1GZM, 1HZX, 1L9H, 1U19, 2G87, 
2HPY, 2I35, 2I36, 2I37, 2J4Y, 2PED, 3C9L, 3C9M (microstates). Figure is adopted from (Bahar et al., 2009). 
 
 
a
h
 6 
1.3 DUAL-SPECIFICITY MITOGEN-ACTIVATED PROTEIN (MAP) KINASE 
PHOSPHATASES (MKPS) 
ecificity protein 
phosphatases (DSPs). They are important signal transduction enzymes that regulate various 
s 
ers under the protein tyrosine phosphatase (PTP) superfamily, which 
is distinguished by the active-site signature motif HCX5R at the phosphatase (PTPase) loop 
(Al
 
and extracellular 
ily show tissue 
tional induction 
profiles (Camps et al., 2000). At least five of these family members have been implicated with 
ember, and the 
P-1 is a nuclear 
ls are elevated in 
st (Wang et al., 2003) and 
lung (Vicent et al., 2004) cancers. MKP-3 is a cytosolic phosphatase with preference for ERKs 
over other MAP kinases. Overexpression of MKP-3 is associated with lung (Chen et al., 2007) 
and pancreatic (Furukawa et al., 2003) cancers. Yet undisclosed therapeutic potentials of MKPs 
have led to a growing cancer medicinal chemistry interest in exploring their biology. 
 
Mitogen-activated protein (MAP) kinase phosphatases (MKPs) are dual-sp
cellular processes, such as growth and differentiation, in opposition with protein kinases. MKP
form a family with 11 memb
onso et al., 2004; Tonks, 2006).  
MKPs dephosphorylate and inactivate MAP kinases (Theodosiou & Ashworth, 2002). 
Their substrates are p38 kinases (p38s), c-Jun amino-terminal kinases (JNKs) 
signaling-related kinases (ERKs) (Jeffrey et al., 2007). Members of the MKP fam
specific expression patterns and tight growth/mitogen/stress regulated transcrip
various cancer types (Wu, 2007). Among these, MKP-1, the prototypical m
structurally well-characterized MKP-3 have been most closely examined. MK
protein and shows selectivity for p38s and JNKs over ERKs. Its expression leve
at least eight cancer types and correlate with the progression of brea
 7 
  removal of two 
ues on the same 
latively shallow 
 
phosphorylated serine/threonine residues which, in contrast to phosphorylated tyrosine, only 
.3 illustrates the 
naling enzymes, 
endent kinase 2 
sites, which ensures the tight binding of small molecule ligands, and allows for the design of 
selective inhibitors. The lack of analogous active site features in MKPs increases the challenge 
for the design of small molecule inhibitors. 
 
MKPs, or in general DSPs, are defined by their ability to catalyze the
covalently attached phosphate groups from tyrosine and serine/threonine resid
substrate. This activity is achieved via the PTPase catalytic mechanism at a re
active site (Figure 1.3); presumably, this shape is required for accommodating the
extend slightly beyond the peptide backbone (Denu & Dixon, 1998). Figure 1
catalytic domain of MKP-5 in comparison to two extensively studied cell sig
protein tyrosine phosphatase 1B (PTP1B) (Puius et al., 1997) and cyclin-dep
(Cdk2) (Bramson et al., 2001). PTP1B and Cdk2 structures have a deep groove at their active 
 
Figure 1.3 Comparison of the active sites of MKP-5, PTP1B and Cdk2. 
MKP active sites are rather shallow, compared to the deep pockets that permit the insertion of ligands in PTP1B and 
Cdk2. Figure is adapted from (Bakan et al., 2008). 
 
 8 
MKP inhibitors have been identified in natural product collections (Vogt et al., 2005), 
 scale drug-like 
 widely used as 
redox properties, 
 
(Lazo et al., 2006). Figure 1.4 presents an overview of the ensemble of proteins targeted by 
approved drugs, retrieved from DrugBank (Wishart et al., 2008), which showcases the small 
fraction of protein phosphatases and the lack of representation of MKPs. 
 
diversity-oriented chemical libraries (Vogt et al., 2003) as well as in larger
compound libraries (Johnston et al., 2007). These compounds have not been
molecular probes or lead compounds in part because of their lack of potency, 
and inadequate phosphatase selectivity, despite some limited synthetic analog follow up studies
 
Figure 1.4 Distribution of biological targets among approved drugs. 
Molecular functions of 1321 approved human drug targets retrieved from DrugBank (Wishart et al., 2008) are 
assigned using the PANTHER classification system (Thomas et al., 2003). Phosphatase and kinase slices are 
 9 
enlarged in two separate pie charts. We note that a much smaller number of protein phosphatases
targets compared to protein kinases, which performs the complementary chemical functio
parentheses represent the numbers of target proteins in each category and their fractional contri
set of approved drug targets. Protein tyrosine phosphatase (PTP) 1b, low molecular weight PTP, s
 are validated as 
n. The numbers in 
bution to the entire 
er/thr-protein 
phosphatase 2A, tyrosine-protein phosphatase non-receptor types 4 are among protein phosphatases. There are no 
MKPs approved as drug targets. MKP-3 is listed in the DrugBank as an experimental drug target. Figure is adopted 
from
very (Jorgensen, 
 discovery and 
n distinct MKP 
structures has more than doubled, providing the framework for developing structure-based 
proving 
interactions of MKPs with their substrates and inhibitors could 
accelerate the discovery and development of therapeutic agents. Here we will focus on two 
ther heir interactions 
with ligands at the molecular level.  
unds that target 
deling the conformational 
flexibility of the protein and (ii) accounting for the entropic effects that stabilize the bound 
inhibitor conformations. While tackling these challenges, we apply the lessons that we learned 
from the analysis of protein-inhibitor complex structure ensembles. After presenting the results 
for MKPs, we finally discuss prospects toward addressing these challenges in general. 
 
 (Bakan et al., 2008). 
 
Computational methods are now ubiquitous in all aspects of drug disco
2004). Particularly, structure-based modeling tools are broadly used in lead
optimization (Shoichet et al., 2002). In the past three years, the number of know
modeling for compounds of therapeutic interest. It is reasonable to hypothesize that im
our understanding of the 
apeutically important MKPs, MKP-1 and MKP-3, and present results on t
 
We face two major challenges in the in silico design of lead compo
MKPs, which are common to most molecular docking efforts: (i) mo
 10 
1.4 MEMBRANE PROTEINS 
y in the transport 
and drug action. 
While approximately 30% of sequenced genes encode membrane proteins, the fraction of 
 to 
s, obtained from 
 
With their locations at cell boundaries, membrane proteins are involved not onl
of endogenous substrates/ions, but also in drug uptake (Dobson & Kell, 2008) 
membrane proteins among drug targets has been estimated to be 70% in 2001 (Stahlberg et al., 
2001). An updated distribution of drug targets is presented in Figure 1.5.  The pie chart refers
965 US Food and Drug Administration (FDA) approved small-molecule drug
DrugBank (http://www.drugbank.ca) as primary source (Wishart et al., 2008), a
and literature (Imming et al., 2006). A total of 380 proteins are targeted by these drugs, m
which belong to the human genome. The corresponding molecular functions, r
PANTHER Classification System (Thomas et al., 2003), are grouped int
categories. 
nd refined using 
Therapeutic Target Database (DB) (Chen et al., 2002), SuperTarget DB (Gunther et al., 2008), 
ost of 
etrieved from the 
o 71 functional 
 The top-ranking 
four categories are G-protein coupled receptors (GPCRs), nuclear hormone receptors, ligand-
gated ion channels (LGIC) and voltage-gated ion channels. These constitute targets for more than 
half of the drugs. These results are consistent with those recently compiled by Hopkins and 
coworkers (Overington et al., 2006), apart from minor differences presumably due to differences 
in the dataset. 
 
Figure 1.5 displays the most frequently targeted ten such categories. 
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 Figure 1.5 Distribution of small molecule drugs based on the targeted molecular function. 
The distribution is shown for the top-ranking ten functional categories targeted by 965 FDA-approved small 
molecule drugs, excluding biotechnology drugs, nutraceuticals such as vitamins and amino acids, and those with 
unce 75% of the drugs in 
given drug targets 
s are 
 and D2 dopamine receptors. All three are 
members of the GPCR family of proteins.  These are succeeded by γ-aminobutyric-acid (GABA) 
A receptor α1, a LGIC. These proteins are still being investigated in relation to a broad spectrum 
of diseases including central nervous system disorders, allergies, inflammation, respiratory 
disorders, headache and sleep disorders (Zheng et al., 2006a).  
rtain targets. The top ten categories shown in the pie chart are associated with more than 
the dataset. The set includes 1008 drug-protein associations. A given category is counted once if a 
multiple proteins in that category. Figure is adopted from (Bahar et al., 2009). 
 
The membrane proteins that are most frequently targeted by small molecule drug
histamine H1 receptors, α1-adrenergic receptors
 12 
 o interact with a 
r animal assays 
 drug discovery 
e of 
assessing drug targets and understanding the mechanistic aspects of drug-target associations 
arget proteins is 
very (Congreve 
ernative protein 
embrane 
proteins. In this work, we also illustrate the utility of ensemble analysis and physics-based 
methods by way of calculations performed for two widely studied receptors: (i) rhodopsin, a 
GPCR, and (ii) nicotinic acetylcholine receptor (nAChR), a LGIC. 
ION 
ures of a protein 
are usually attributed to induced fit, in the absence of data supporting alternative mechanisms or 
a thorough analysis of protein’s dynamics. In a number of recent studies, the X-ray structural 
(James et al., 2003), NMR (Lange et al., 2008; Gsponer et al., 2008), or theoretical data (Tobi & 
Bahar, 2005; Ivetac & McCammon, 2009) provided evidence for the existence of a 
Notably, most of the drugs currently in use were not initially developed t
specific target protein, but to induce certain phenotypes in cultured cell o
(Filmore, 2009). The identification of the targets followed the completion of the
process (a trial-and-error process using combinatorial chemistry rules).  The importanc
became clear only in recent years. Knowledge of structure and dynamics of t
now recognized to be a crucial element in making progress in rational drug disco
et al., 2005). We think that simple models and methods for sampling alt
conformations may be beneficial to computational discovery efforts targeting m
 
1.5 SPECIFIC AIMS AND OUTLINE OF THE DISSERTAT
 
The conformational changes observed between ligand-bound and unbound struct
 13 
conformational selection (or pre-existing equilibrium) mechanism in complex formation, in 
udies, the role of 
led out, but was shown to follow conformational selection, 
rather than drive it, and be rather localized.  
 
The interactions of proteins with small-molecule drug are even more difficult to interpret 
d, the conformational changes 
observed in the ligand-bound structure are accepted to be ligand-induced, regardless of their 
mag   
In the present study, we hypothesized that the same mechanisms that govern the 
and that a small-
ation that is pre-
tation of binding 
affect are the large-magnitude collective motions of 
the protein, such as those engaging entire domains. A thorough comparative analysis of the 
As detailed later, we systematically searched for targets with multiple diverse structures 
and performed a comparative analysis. On the practical side, we aimed at incorporating protein 
backbone flexibility into modeling protein-ligand interactions in order to account for the 
conformational effects that are usually omitted in docking simulations. To this aim, we sampled 
particular for protein-protein interactions. Yet, it should be noted that in these st
induced-fit was not necessarily ru
. For many widely studied targets, including those we have studie
nitude (Cavasotto & Abagyan, 2004; Ragno et al., 2005; Hyeon et al., 2009).
 
dynamics of protein-protein interactions also apply to protein-drug interactions; 
molecule drug can induce local changes only after selecting a protein conform
disposed to binding. These local changes may be side-chain rotations or re-orien
loops. Those beyond the ability of drugs to 
growing data in the Protein Data Bank (Berman et al., 2000) shall enable us to elucidate the 
contribution of these two complementary mechanisms. 
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multiple protein backbone configurations prior to docking, and then generated bound-ligand 
igand and amino 
 biological side, we aimed at understanding and modeling MKP 
inte actions with their inhibitors. 
Our studies have been reported in five publications, consisting of three research and two 
 (2009). The intrinsic dynamics of enzymes plays a dominant role 
roc. Natl. Acad. 
Sci. U.S.A, 106, 14349-14354. 
We er detail in Sections 2 
ree articles: 
• Lazo, J. S., Skoko, J. J., Werner, S., Mitasev, B., Bakan, A., Koizumi, F., Yellow-Duke 
an mitogen-
amide library. J 
r., 322, 940-947. 
• Bakan, A., Lazo, J. S., Wipf, P., Brummond, K. M., & Bahar, I. (2008). Toward a 
molecular understanding of the interaction of dual specificity phosphatases with 
substrates: insights from structure-based modeling and high throughput screening. Curr. 
Med. Chem., 15, 2536-2544. 
conformations for each protein conformer by considering the flexibilities of the l
acid side chains. On the
r
 
review articles. We published our results from comparative study of target protein structural 
ensembles and intrinsic dynamics of proteins in: 
• Bakan, A. & Bahar, I.
in determining the structural changes induced upon inhibitor binding. P
 discuss these results, and the methods and tools of this research in great
and 3.  
 
The results from our studies of MKP inhibitors have been published in th
A., Bahar I., Brummond K.M. (2007). Structurally unique inhibitors of hum
activated protein kinase phosphatase-1 identified in a pyrrole carbox
Pharmacol. Exp. The
 15 
• Molina, G.*, Vogt, A.*, Bakan, A.*, Dai, W., Queiroz de, O. P., Znosko, W., Smithgall 
emical screening 
 of Dusp6 that expands cardiac cell lineages. Nat. Chem. Biol., 5, 680-
We discuss these results and methods in Sections 2 and 4. 
 
brane proteins in 
a, I. H. (2009). Normal Mode Analysis 
s of Membrane Proteins. Chem. Rev. 
Published online DOI: 10.1021/cr900095e (*: equal contribution) 
 While we fulfilled most of our specific aims, new questions arose in relation to dynamics 
of protein-ligand interactions and to dynamics and inhibition of MKPs. We discuss these 
questions and our short-term plans to address them in the Discussion. 
T.E., Bahar I., Lazo J.S., Day B.W., Tsang M. (2009). Zebrafish ch
reveals an inhibitor
687. (*: equal contribution) 
Finally, we reviewed the methods we used and their applications to mem
a Chemical Reviews article: 
• Bahar, I., Lezon, T. R.*, Bakan, A.*, & Shrivastav
of Biomolecular Structures: Functional Mechanism
We briefly present some results for two membrane proteins in Section 5. 
 
 16 
2.0  THEORY AND METHODS 
 
tion of proteins 
hen modeling of 
f side-chains is 
(Dunbrack, Jr. & Karplus, 1993) or Lovell (Lovell et al., 2000). Yet, there are no standard means 
docking. For our 
from structural 
rium dynamics using physics-based models. We will apply 
what we learn from the analysis of structural ensembles to MKPs, and we will combine those-
residue level approaches with those based on all-atom models toward making a more detailed 
 will be used for 
CG analysis of backbone equilibrium dynamics: principal component analysis (PCA) and 
anisotropic network model (ANM) analysis. The former is applied to the analysis of ensembles 
of experimentally resolved structures. The latter is a predictive model. The two approaches 
therefore provide information based on experiments and theory, respectively. Second, we will 
In this thesis, we are primarily interested in changes in the backbone configura
targeted by drugs, which will be shortly referred as drug targets or targets. W
protein and small-molecule interactions, the conformational variability o
efficiently taken into account by using rotamer libraries, such as those developed by Dunbrak 
of incorporating complete backbone flexibility in, for example, molecular 
purposes, a residue-level representation of proteins is sufficient to learn 
ensembles and to model the equilib
assessment of its interactions with inhibitors.  
 
In this section, we begin by describing two fundamental approaches that
 17 
show how to compare the protein motions predicted by these two methods. Third, we describe 
n this work, and 
cribe supporting 
ch as surface electrostatic potential calculations which will be used in assessing 
druggable sites. 
2.1 PRINCIPAL COMPONENT ANALYSIS (PCA) OF STRUCTURAL ENSEMBLES 
Principal component analysis is an orthogonal linear transformation that transforms data from the 
fied view of the structural 
variability in the examined dataset by identifying the directions of dominant structural changes. 
The ataset lies along 
the first principal component (PC) axis, and then along the 2nd PC axis, and so on.  
 
n on equilibrium 
 the PDB for the 
ligands. Alternatively, ensembles of NMR 
models or simulation snapshots may be used (Yang et al., 2008; Yang et al., 2009). The utility of 
PCA for understanding functional dynamics is clearly demonstrated by a recent study of 
ubiquitin structures in which a single mode of motion was found to largely account for the ability 
of ubiquitin to recognize a range of substrates (Lange et al., 2008). 
all-atom models and methods (e.g. force fields and docking) that will be used i
describe how we combine low-resolution and all-atom models. Fourth, we des
methods, su
 
Cartesian coordinate system into a new system of collective coordinates (Jolliffe, 2002).  Its 
application to ensembles of structures aims at gaining a simpli
 new coordinate system is such that the maximum possible variance in the d
Here, we focus on the application of PCA methods to extract informatio
dynamics. PCA is performed in this case for an ensemble of structures hosted in
same protein determined in the presence of different 
 18 
 2.1.1 Iterative optimal superimposition of structures 
structures in the 
ensemble so that they are all expressed in the same reference coordinate system and their 
differences in the external degrees of freedom (rigid-body translation and rotation) are 
elim n. 
of N residues. Each 
conformation, k, is described by a 3N-dimensional vector consisting of the position vectors Ri(k) = 
(xi(k i(k)  zi(k))T of the N α-carbons (1 ≤ i ≤ N) in that particular conformation, organized as  
q(k) = ((R1(k))T, …., (RN(k))T)T = (x1(k), y1(k), …, xN(k), yN(k) , zN(k))T   (2.1.1) 
 
(k) (k) – q0 for each 
rs of the N sites 
 positions are 
identified by the average coordinates over all optimally superimposed PDB structures. The 
optimal superimposition is an iterative procedure and consists of the following steps: (i) Each 
structure in the ensemble is first pairwise superimposed onto a randomly selected reference 
structure using the Kabsch algorithm (Kabsch, 1976). This algorithm minimizes the root-mean-
The first step before performing PCA is to transform (rotate and translate) all 
inated. This type of transformation will be called the optimal superimpositio
 
Let us consider an ensemble of M conformations, for a protein 
)  y
 
 
Note that superscript T stands for transpose, and q(k) is a column vector. 
Similarly, we define a 3N-dimensional fluctuation vector Δq  = q
conformation, describing the departure ΔRi(k) = Ri(k) – Ri0 in the position vecto
from their equilibrium position Ri0 = (xi0  yi0  zi0)T (Figure 2.1). The equilibrium
 19 
squared deviation (RMSD) between a given pair of structures. Essentially, the Kabsch algorithm 
RMSD, after the 
 of CoM of the 
uperimposed set 
erimposed 
on the newly generated ‘average model’ using the Kabsch algorithm, (iv) steps (ii)-(iii) are 
 by less than the 
ns. The present 
translational and 
from a NMA that describe purely internal motions. This iterative approach is implemented using 
Python scripting language and Molecular Mechanics Toolkit, as described below. 
 
finds the rotation matrix for the superimposed structure that will minimize the 
center of mass (CoM) of the superimposed structure is moved to the position
reference structure. (ii) An average set of coordinates is calculated for the s
obtained in (i), referred to as the ‘average model’, (iii) all structures are pairwise sup
repeated until the average model generated in two successive iterations changes
threshold RMSD of 0.001Å. This procedure usually converges in 3-5 iteratio
superposition method ensures that the structures do not undergo rigid body 
rotational motions, and allow for direct comparison of the deformation vectors with eigenvectors 
 
Figure 2.1 Schematic representation of a protein configuration. 
In the equilibrium conformation, the positions of the α-carbons i and j are designated respectively as Ri0 and Rj0, and 
the vector Rij0 = Rj0 – Ri0 defines the distance vector between these sites.  In the kth conformation in the ensembles, 
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atoms move to Ri  + ΔRi  and Rj  + ΔRj , and the distance vector becomes Rij .  The solid b
the structural details of the initial-state of the protein ba
0 (k) 0 (k) (k) lack curve represents 
ckbone, and the broken black curve indicates its state after a 
change in configuration. Figure is adapted from (Bahar et al., 2009). 
 
2.1.2 Covariance matrix: a measure of correlations between residue fluctuations 
tions in different 
e cross-correlations between the components of the fluctuation vectors 
are given by the averages <Δqi Δqj> over all conformations. These values can be organized in a 
3N t
 
C = (1/M) Σk Δq(k) Δq(k)T       (2.1.2) 
 
whe a protein of N 
residues. 
 
The covariance matrix C provides a detailed description of equilibrium motions, 
including the mean-square fluctuations in the individual interaction sites and their cross-
correlations. The elements of C may be organized in submatrices of size 3x3 as 
 
Cij =      (2.1.3) 
 
It is of interest to understand the type and strength of coupling between the varia
degrees of freedom. Th
x 3N covariance ma rix C, 
re Δq(k) denotes the 3N-dimensional fluctuation/displacement vector for 
⎥⎥
⎥
⎦
⎤
⎢⎢
⎢
⎣
⎡
>ΔΔ<>ΔΔ<>ΔΔ<
>ΔΔ<>ΔΔ<>ΔΔ<
>ΔΔ<>ΔΔ<>ΔΔ<
)zz()yz()xz(
)zy()yy()xy(
)zx()yx()xx(
jijiji
jijiji
jijiji
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where i and j vary in the range [1, N], both. C may thus be viewed as an NxN super matrix, the 
super elements of which are defined by Equation 2.1.3. 
or, and lightface 
ents of vectors or matrices). The sum of the diagonal elements of 
Cij,  
 
(2.1.4) 
j of sites i and j. 
The mean-square fluctuations in the positions of individual sites are given similarly by the trace 
of the diagonal submatrices, i.e., tr{Cii} = <(ΔRi · ΔRi)> = <(ΔRi)2> using i = j in Equation 2.1.4. 
In many applications, it proves useful to analyze the NxN covariance matrix, 
 
Here, we use boldface subscripts to designate a (sub)matrix or vect
subscripts for scalars (e.g., elem
tr{Cij} = <Δxi Δxj > + <Δyi Δyj > + <Δzi Δzj > = <ΔRi · ΔRj >  
 
provides a measure of the cross-correlation between the fluctuations ΔRi and ΔR
C , composed of the 
correlations between the fluctuation vectors ΔRi, themselves,  
 
C = 
⎤
⎢⎢
⎢ >Δ<>ΔΔ<
....
.... )(.
..
2
2
212
....
RRR (2.1.5) 
Note that the elements of 
⎥⎦⎢⎣ >Δ<>ΔΔ<  )(.. . 2N1N .. RRR    
 
⎢⎡ >ΔΔ<>Δ< .. . )( 211 RRR
C
⎥⎥
⎥⎥
are given by Equation 2.1.4.  
 
The fluctuations in the Cartesian space are mapped onto the space spanned by the 3N (or 
N) principal axes upon diagonalizing the covariance matrix C as 
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C = P S PT k pk        (2.1.6) 
ong the principal 
mn vector pk, (1 
1 2 N
order, in this case. The eigenvalues are directly proportional to the variance along the principal 
axes. Therefore, the fractional contribution of displacements along pk to the structural variability 
in t
 
k k i i (2.1.7) 
 
 summation is performed over all 3N modes. Equation 2.1.6 permits us to assess the 
contribution of each mode, or subset of modes to the observed variance in the ensemble. For 
exa  displa  the top ranking m 
PC modes is  
 
(ΔRi)2|1 ≤ k ≤ m = tr{[ }      (2.1.8) 
2.1.3 Projection of conformations onto the subspace spanned by the PCs 
The projection of a given conformational change ΔRs onto pk is found from  
 
 = ∑ =Nk k3 1σ p T 
 
In Equation 2.1.6, P is the unitary matrix of normalized displacements al
axes, also called the principal modes of structural changes, each given by a colu
≤  k ≤ 3N), and S is the diagonal matrix of eigenvalues σ , σ ,  …, σ , ordered in descending 
he dataset is  
f  = σ /Σ σ ,          
where the
mple, the square cements in the position of the ith residue induced by
∑ =mk k1σ pk pkT]ii
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cks =(ΔR )  pk         (2.1.9) 
 along pk, cks = ||ΔRs||, where the double bars 
designate the magnitude. This will be illustrated in Figure 3.4. 
 
erforming PCA. 
x3N matrix that 
contains coordinate data from the ensemble after the iterative optimal superimposition of 
res 
 termini. Hence, 
oordinates. SVD 
verage positions 
calculated for residues with missing coordinates. The covariance method enables to calculate the 
ensem
sentation of the 
In our analyses of X-ray ensembles, we included data on the residues that are resolved in 
90% of the structures, omitting those portions not resolved. This resulted in considering around 
90% of the target protein in each case (see Tables in Appendix A for a list of residues considered 
in each dataset of protein structures). When this threshold was relaxed (i.e. a larger portion of the 
s T
 
In the extreme case of ΔRs perfectly aligned
2.1.4 A note on the analysis of X-ray ensembles 
In this work, covariance matrix diagonalization is the preferred method of p
Alternatively, one may perform singular value decomposition (SVD) on the M
structures (Jolliffe, 2002). Covariance method is preferred over SVD, because X-ray structu
contain missing data, on usually flexible parts of the protein, such as loops and
the Mx3N data matrix may contain zeros at positions corresponding to missing c
on such a data matrix may result in ill-defined principal modes due to incorrect a
ble averages properly. The averages for each submatrix Cij are taken over all existing pairs 
of residues. Hence, the calculated principal modes provide a robust repre
dominant features of the essential dynamics.  
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protein was considered), the PCA was unable to capture collective motions. The first few 
 loop residues. 
ed the agreement 
itting more than 
 to capture 
collective motions and preserving the structural integrity of the protein. In fact, de Groot and 
 fraction of residues from the C-terminal part of ubiquitin (6 out 
of 76 residues; 8%) because the random fluctuations at this region obscured the collective and 
functional motions (Lange et al., 2008). 
 
ETWORK 
Normal mode analysis is an analytical means of evaluating the type and size of collective 
motions accessible to a mechanical system in a harmonic potential energy well (Cui & Bahar, 
980s (Brooks & 
3; Go et al., 1983; Naik et al., 1984; Levitt et al., 1985). However, only in the last 
decade has it become a tool widely used for exploring functional motions. A major reason behind 
its broader use is the observation that global modes elucidated by NMA bear functional 
significance. This feature became evident with the use of simplified models in CG NMA (Bahar 
& Rader, 2005). 
 
principal modes described, instead, the random fluctuations of termini and
Increasing the threshold (i.e., including a smaller portion of the protein) increas
between experimental (PCA) and computational (ANM) data, but resulted in om
10% of the sequence. 90% threshold achieved a reasonable balance between ability
coworkers did exclude a similar
2.2 A NORMAL MODE ANALYSIS BASED ON ANISOTROPIC N
MODEL (ANM) 
2006; Bahar et al., 2009). Its application to proteins dates back to early 1
Karplus, 198
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The underlying assumption in NMA is that the effective potential between interacting 
ssed as a sum of 
ly simplifies the 
e validity of the 
harmonic approximation decreases as the system is displaced away from its equilibrium 
bond length and 
nsidered. Distortions 
along the normal modes may violate such constraints (Song & Jernigan, 2006; Yang et al., 
2007). These lim inimum.  
 
of biomolecular 
lly represent the 
ndscape become 
states, separated by low energy barriers 
become accessible. Such substates are usually sampled by local rearrangements such as rotations 
) movements of entire secondary structural elements or domains 
which involve changes in a minimal number of degrees of freedom. 
2.2.1 Normal Mode Analysis (NMA) 
NMA is based on the diagonalization of a 3N x 3N matrix called the Hessian, H. We described 
below the construction of H and calculation of normal modes.  
pairs of atoms, or residues when the system is modeled at a CG scale, is expre
harmonic potentials between all interacting pairs. While this assumption great
analysis of slow and energetically favorable motions of the system, it limits th
analysis to the proximity of the initial, or the equilibrium, conformation. The validity of the 
conformation. A second caveat arises when NMA does not explicitly contain 
bond angle constraints, especially when a residue level representation is co
it the accuracy of NMA to the immediate vicinity of the energy m
NMA performed using elastic network model (ENM) representations 
systems are particularly useful for predicting large-scale motions. ENMs typica
protein at residue level. At this level of resolution, fine details of the energy la
smoothed (Figure 1.2). Different conformational sub
of side-chains or global (en bloc
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2.2.1.1 Hessian matrix 
m containing N 
. We omit the 
 (M = 1).  Near the equilibrium 
conformation, q0, the potential energy can be expanded as a power series in q as 
 
For our purposes, the physical system under consideration is a molecular syste
residues, the Cartesian coordinates of which are given by Equation 2.1.1
superscript k here, since NMA is performed for a single structure
( ) ( ) ( ) ( )( ) ...
2
1
,
00
0
2
0
0
0 +−−⎟⎟⎠⎝ ∂∂⎠⎝ ∂ jii qqq
 
where the superscripts ‘0’ indicate the equilibrium conformation.  The first term
⎞
⎜⎜
⎛ ∂+−⎟⎟
⎞
⎜⎜
⎛ ∂+= ∑∑ ji jjiii ii qqqqVqqVVV qq
 is the value of 
the potential at the energy minimum, which may be set to zero.  When the equilibrium 
conformation is at the minimum of the potential energy landscape, the first order derivative of 
the potential energy function is also zero, by definition.  Hence, to a second order approximation, 
the potential is then a sum of pairwise potentials: 
 
    (2.2.1) 
( )(∑ −− )⎟⎞⎜⎛ ∂= qqqqVV 00
0
21)(q ⎟⎠⎜⎝ ∂∂ij jjiiji qq2  
( ) ( ) qHqT ΔΔ=−−= ∑ 2121 , 00ji jjijii qqHqq     (2.2.2)  
 
where H is the Hessian matrix obtained from the second derivatives of the potential with respect 
to the components of q (or Δq): 
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0
2 ⎞
⎟⎟⎠⎜
⎜
⎝
⎛
∂∂
∂=
ji
ij qq
VH        (2.2.3) 
ht of as an N×N 
atrices, each of which refers to the energetic contribution from the 
interaction of two residues.   
st, H is real and 
mation.  Second, 
potential energy 
minimum.  The sign of a given eigenvalue indicates the local curvature of the potential along the 
 indicate local 
 landscape for a 
 in all directions.  
 no effect on the 
system’s (internal) potential energy.  Typically, H has 6 zero eigenvalues, corresponding to the 
rigid-body rotations and translations of the molecule. Eigenvectors corresponding to smaller 
eigenvalues describe directions of deformations that are energetically favorable when compared 
to higher ranking eigenvectors (those with larger eigenvalues), as will be shown in the next 
subsection. 
 
 
 
In the same way as the covariance matrix C is organized, H may be thoug
matrix of 3×3 subm
 
Two important properties of the Hessian arise from Equation 2.2.3. Fir
symmetric by definition, and is therefore diagonalized by an orthogonal transfor
none of the eigenvalues of H can be negative if H is constructed at a local 
corresponding mode directional vector, or eigenvector: Positive eigenvalues
minima, and negative eigenvalues, local maxima.  The local potential energy
system in a potential energy minimum will have only positive or zero curvature
Eigenvalues that are identically zero indicate conformational changes that have
 28 
2.2.1.2 Normal modes 
t for the kinetic 
 matrix that is to 
 of the normal 
a collection of classically behaving particles 
(oscillators), the equation of motion can be written as 
 
Normal modes are calculated by solving the equation of motion that accoun
energy as well as the potential energy of the system.  In this case, the form of the
be diagonalized slightly changes, but this clarifies the physical interpretation
modes.  By considering the system to be 
02dt
 
a a
Δ2 =Δ+ qHqM d         (2.2.4) 
Here, the diagonal m trix M contains the m sses of the nodes.  Each mass is repeated three 
times, once for each of the node’s three Cartesian coordinates.  A solution to Equation 2.2.4 is 
the N-dimensional vector uk(t) = ak exp{-iωkt}, where ak is a complex vector containing both 
amplitude and p resented by uk(t).  
Substituting this solution into Equation 2.2.4, the equation of motion becomes 
 
(2.2.5) 
which is a generalized eigenvalue equation. The complete set of solutions uk(t), 1 ≤ k ≤ 3N, and 
the correspon e columns of the 
matrix  and the elements λk = ωk2 of the diagonal matrix Λ to rewrite the set of 3N equations 
represented by Eq. 12 in compact notation as 
 
         (2.2.6) 
3
hase factor, and ωk is the frequency of the mode of motion rep
kkk ΜuHu ω=          
 
2
ding squared frequencies ωk2 may be organized as the respectiv
U
MUΛHU =
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 Equation 2.2.6 can be transformed into a standard eigenvalue equation ΛUUH ~~~ =  in 
mass-weighted coordinates through the transformations UMU
21~ =  and 2121~ −−= MH
ighted Hessian, H
HM
mass-we
.  The 
~ , retains the try of the original Hessian, and
2/1
 symme  its eigenvectors 
kk uMu~ = form an orthonormal basis set (i.e., 1UU =~~ T ).  These are the 
system. Their Cartesian counterparts d thr ugh the inverse transforma
normal modes of the 
are foun tion o UMU ~21−=  
and satisfy the orthonormality condition UTMU = 1.  If the nodes have all equal mass m, M 
reduces to the identity m multiplied by m, atrix 1 2= /mU U%  and H~ = m-1 H. When all nodes in the 
system are assumed have unit masses, energetic modes and normal modes become identical. 
 
The energy associated with a given normal mode is directly proportional to the square of its 
frequency (or its eigenvalue λ  = ω 2).  This can be seen by rewriting Equation 2.2.2 for a single 
mode k: 
2.2.1.3 Interpretation of Normal Modes: Significance of slow modes 
k k
 
( )
22
1 2
kkk
ω
        
 
kTV == Huuu
(2.2.7) 
Displacements along high-frequency modes are therefore energetically more expensive 
than those of equal magnitude along low-frequency modes.  The vibrational energy is, on 
average, equally partitioned among all the modes, such that the average amplitude of oscillation 
along mode k scales with 21 kω .  Thus, the molecule experiences the greatest displacement along 
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the lowest frequency, or ‘slowest’ modes, hence their qualification as ‘soft modes’.  These 
probable global 
her hand, indicate directions of steep 
energetic ascent, subject to high frequency, low amplitude fluctuations.  
The cross-correlations <Δqi Δqj> between the displacements of the interaction sites along 
different coordinates are calculated as statistical m ical averages of the form  
modes are also of highest interest when seeking to determine the most 
fluctuations of a molecule.  Large eigenvalues, on the ot
 
echan
( )ijBjiTkNji d TkqqeqZqq =ΔΔ ∫ 
T
B 12
1
631 −ΔΔ−− =ΔΔ HqHq ,            (2.2.8) 
 
using the configurational integral 
 
( ) ( )[ ] 2112632   163 det2 −ΔΔ− == ∫ HqHq BTkN TkeqdZ TB π                    
  
Here the integrations are performed over the complete space of equilibrium fluctuations, 
ij 
inverse of H.  Because of the way the elements of H are defined (i.e. the d
found from the negative sum of off-diagonal 
−− N (2.2.9) 
kB is the 
Boltzmann constant, T is the absolute temperature, and (H-1) designates the ijth element of the 
iagonal elements 
terms), the columns/rows are not independent, and 
H is not invertible (its determinant is equal to zero). H has exactly six eigenvalues that are 
identically zero, corresponding to the three translational and three rotational degrees of freedom.  
The inverse of H is therefore replaced by the pseudo-inverse, which is the inverse evaluated only 
in the space corresponding to the non-zero eigenvalues,  
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ωH         (2.2.10) 
hted i ions: The lowest 
the spatial partition function because 
 
The importance of the slow modes is again highlig n these equat
frequency modes contribute most to ( )1~det −H  is the product 
of the reciprocal nonzero eigenvalues of H~ . 
al ensembles 
The cross-correlation <Δqi Δqj> on the left-hand side of Equation 2.2.8 is simply the ijth element 
of the covariance matrix C; therefore Equation 2.2.8 may be rewritten in compact notation as 
(2.2.11) 
ations and NMA 
er case the top-ranking (principal) modes of structural changes 
are extracted from experimental data (or sets of known structures for a given protein). In the 
one structure to 
The top-ranking modes obtained by PCA should, in principle, be comparable to the 
lowest frequency modes derived by NMA (i.e. λi ~ 1/σi, and pi ~ ui), provided that (i) the dataset 
of conformations subjected to PCA represents an equilibrium distribution, and (ii) the Hessian in 
NMA provides an accurate description of dominant interactions. Recent PCAs performed for 
 
2.2.1.4 Covariance computed from NMA: Bridging with PCA of structur
 
C = kBT H-1          
 
This equation establishes the bridge between the PCA of ensembles of conform
of a given structure. In the form
latter, the same such structural changes are predicted by the theory using 
construct H.  
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ensembles of PDB structures exhibit good agreement with the global modes predicted by CG 
dopted in those 
ved from sets of 
nditions, in the 
the use of ENMs for assessing functional changes 
in structure.  
The ANM, owing to its simplicity, is one of the most commonly used ENMs (Doruker et al., 
ates the 
pled by uniform 
d each edge is a 
ach accepts a PDB structure as the global energy minimum; hence the 
computationally expensive energy minimization step is not necessary. In the ANM, the network 
tructure, with edges placed between nodes within a pre-
2.2.2.1 Assumptions and Model Parameters 
Comparisons of predicted root-mean-squared (RMS) fluctuations to motions inferred from 
crystallographic B-factors have identified optimal cutoff distance of 18Å for the ANM (Eyal et 
al., 2006).   As to the spring constants, the simplest ENMs use a uniform force constant for all 
NMAs (Yang et al., 2008; Yang et al., 2009). Notably, ENMs have been a
NMAs. The relevance of ENM predictions for a given protein to PC modes deri
structures experimentally resolved for the same protein (under different co
presence of different ligands) lends support to 
     
2.2.2 ANM: Theory and Foundations 
2000; Atilgan et al., 2001; Tama & Sanejouand, 2001; Eyal et al., 2006). It approxim
protein’s potential energy as that of a classical network of identical masses cou
springs: each node in the network may correspond to an atom or a residue, an
spring. This appro
topology is defined by the native s
specified cutoff distance. 
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interactions. Hinsen proposed using a force constant that decays rapidly with distance (Hinsen, 
ld vary with the 
iffer springs for 
s or amino acid-specific force constants has been shown to 
improve the agreement with experiments.  
odes, 
ly recognized to 
everal studies to 
2005; Nicolay & 
Sanejouand, 2006; Zheng et al., 2006b) and almost identically reproduced at various hierarchical 
levels of resolutions (Doruker et al., 2002; Chennubhotla & Bahar, 2006; Chennubhotla et al., 
des permits us to utilize the ANM as shown below. 
 
2.2.2.2 Potential Function and the Hessian 
 
 
1998). Sen and Jernigan empirically investigated how the force constant shou
coordination number of residues (Sen & Jernigan, 2006).  The adoption of st
sequentially neighboring residue
 
The choice of the specific spring constants has little, if any, effect on the global m
which are the primary focus of this work. The global modes of motion are wide
be intrinsic properties of the 3D shape of the protein, and have been verified in s
be insensitive to model parameters (Doruker et al., 2002; Ma, 2005; Lu & Ma, 
2008). This robustness of global mo
ANM analysis is simply a NMA subject to the potential (Hinsen, 1998)  
( )∑ −= ij ijijij RRV 2021 γ                                                     (2.2.12) 
 
Using this expression in Equation 2.2.3, it is possible to readily write a closed form expression 
for H as  
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Using the notation ( )000 ijij xxx −=  and similar expressions for the three components of the 
instantaneous distance vector R0ij, the off-diagonal 3x3 submatrices of H take the form 
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zxyxx
R
γ
H        (2.2.14) 
 
and the diagonal submatrices satisfy the identity 
 
;
H                                                                  (2.2.15) 
 
The above sim ine the 
collective dynamics.  
 
dies by adopting 
ino acids i and j 
connected by a spring in the network. However, in most applications, γij is taken as a constant, γ, 
for all pairs of residues connected in the network. Equation 2.2.12 with a single parameter γij = γ 
has been originally used by Tirion for representing interatomic interactions (as opposed to inter-
residue interactions considered in all succeeding ENM studies, starting from the Gaussian 
∑iiH ≠−= ijj ij
ple expressions for the elements of H are readily used in NMA to determ
We note that amino acid specificity can be included in ENM-based stu
residue-specific force constants, γij, that are dependent on the identity of the am
 35 
Network Model (Haliloglu et al., 1997; Bahar et al., 1997) based on the statistical 
. Several studies 
oduce the global 
ve, the absolute 
shapes (i.e., the 
eigenvectors, uk, (1 ≤ k ≤ 3N-6) of H), but their frequencies, because the eigenvectors represent 
 the other hand, 
tive mobilities is 
lute sizes of all 
to specific inter-residue interactions, or the adoption of residue-specific force constants. The 
most important determinant of global modes is the connectivity of the matrix, itself, regardless of 
nect the nodes (residues). 
 
2.2.2.3 Generation of Alternative Conformations Using the ANM 
 alternative conformations (substates or 
microstates) in the close neighborhood of a given structure. These are generated upon deforming 
the original structures along the softest modes determined by ANM analysis. Similar to Equation 
2.1.8, the square displacement of residue i contributed by the movement along a given mode k is 
given in terms of the kth eigenvector (uk) and eigenvalue (λk) of H as 
 
thermodynamics of polymer networks, and other CG ENMs such as the ANM
demonstrated to date the ability of these CG models to almost identically repr
modes obtained by atomic NMA that use detailed force fields.  As mentioned abo
value of γ for a given level of representation does not affect the mode 
distributions of mobilities, irrespective of the eigenvalues. The eigenvalues, on
are proportional to γ. In other words, the same distribution of motions, or rela
obtained, irrespective of the choice of g, which uniformly scales the abso
residues’ motions. Previous studies also showed that the global modes are practically insensitive 
the weight (or stiffness) of the edges (or springs) that con
 
A major utility of the ANM is its ability to generate
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(ΔRi) |k = tr{[ k ]ii}       (2.2.16) 
Or the alternative conformations induced upon moving along a given mode are simply,  
q(k) = ((R1(k))T, …., (RN(k))T)T  = ((R10)T, …., (RN0)T)T ± s λk -1/2uk  (2.2.17) 
 
½  in the absolute 
se to movements 
comparable in size to those experimentally observed is generated, and used for further 
calculations, such as generating an ensemble of conformations to be used in docking simulations. 
A AND ANM 
Wh hat information to 
select effective normal modes to achieve a given transition. T contribution of these modes, i.e., 
f s in Equation 2.2.17, is usually based on the correlation cosine, or overlap  
 
Ok = (ΔqAB · uk)/| ΔqAB|,         (2.3.1) 
 
between the normalized directional vector uk and the targeted direction of deformation ΔqAB = 
q(B) – q(A) provided that the goal is to explore the transition from substate A to B (Marques & 
2 Tλk-1 uk u
 
 
where the coefficient s scales with (kBT) .  In principle, given the uncertainty
value of γ, which is reflected on the eigenvalues, a range of s values giving ri
 
2.3 COMPARISON OF ESSENTIAL MODES DERIVED FROM PC
ANALYSIS 
en the structure of a protein is known in alternative forms, one can use t
the choice o
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Sanejouand, 1995). Similarly, the overlap between the PCA mode i and the ANM mode j may be 
calculated as 
 Oij = pi · uj         (2.3.2) 
Note that ANM modes define a complete space of conformational changes, i.e., each eigenvector 
may be viewed as a component/axis of a complete 3N-6 dimensional orthonormal basis set. As a 
result, the summation over all m
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1
N
j
(2.3.3) 
rom experiments 
 the top ranking 
e softest 3 ANM 
modes will exhibit the closest correspondence to top-ranking experimental modes. In some cases, 
the com
ta (e.g. the case of calmodulin 
discussed in the next chapter). 
 
In the comparison of PCA and ANM, another quantity of interest is the cumulative 
overlap that describes the contribution of subsets of ANM modes to a PCA mode  
 
 
 
odes satisfy the relation, 
∑ =1ijO          
 
In the following chapter, when we compare the PCA modes derived f
with the ANM-predicted normal modes, we will seek a correspondence between
3 PCA modes and softest 20 ANM modes. It will be seen that one of the thre
−
=
bination of two slow modes will be shown to reach a significant level of correlation 
(correlation coefficient around or above 0.7) with experimental da
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=
J
j
ij
J
i OCO          (2.3.4) 
, usually starting 
ove, this summation is identically equal to unity if 
it is performed over all 3N-6 modes/eigenvectors. 
Finally, the subspace overlap between the PCA and ANM essential spaces spanned by I 
PCA and J ANM modes, respectively, is found from (Amadei et al., 1999) 
 
  
where the summation is performed over the subset of ANM modes of interest
from the lowest-lying modes. As explained ab
 
( ) 21
1 1
21 ⎥⎦
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= =
I
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J
j
ij
IJ O
I
SO        (2.3.5) 
 
2.4 ALL-ATOM MODELS OF PROTEINS 
CA calculations 
 small-molecules 
m representation 
of the protein structure and energetics is an inevitable ingredient of our modeling studies. In all-
atom representations of proteins, or in general of chemical entities, electrons are generally 
ignored and each atom is represented by the position of its nucleus with a mass and partial or full 
charge (Leach, 2001). This is the most common representation of molecular structures in MD 
A residue-level representation of the protein structure is adopted in ANM and P
as explained above. However, understanding the interactions of proteins with
requires consideration of chemical specificity at atomic scale. Hence, an all-ato
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simulations and in modeling protein-ligand interactions. Finer representations with full or partial 
ly applicable to 
mall number of atoms, in the orders of ten, due to the substantially increased 
com
 
ed by molecular 
or each element 
to capture the differences in its chemical environment in different molecules (Leach, 2001). For 
 types due to 
number of atom 
een chemically 
from quantum 
mechanical calculations of small representative compounds and are fitted to experimental 
spectral and/or thermodynamic data, hence are also called empirical force fields. A typical 
pot t unc  is co  and non-bonded 
interactions (Leach, 2001; Wang et al., 2004; Brooks et al., 2009). The total potential energy of 
the system is written as the sum of bonded and non-bonded potential energies: 
 
VFF = Vbonded + Vnon-bonded       (2.4.1) 
 
electronic detail such as quantum mechanical or semi-empirical methods are on
systems with s
putational cost. 
2.4.1 Force Fields 
All-atom representations of molecules are commonly and conveniently describ
mechanics (MM) force fields (FFs). FFs contain multiple atom type definitions f
example, oxygen atoms in ether and ester groups are described using different atom
the differences in their bonded atoms and bond orders. FFs generally limit the 
types per element, which makes it feasible to parameterize the potentials betw
bonded or physically interacting atom pairs. FF parameters are derived 
en ial f tion mposed of additive components describing bonded
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Bond length and bond angle potentials are defined as quadratic functions around their 
and, involve four 
ined as a sinusoidal function. The contribution of bonded 
inte ctions to the total energy may be written as: 
 
 
2 2 – φ))  (2.4.2) 
, kcal/mole/rad2, 
0 0 ψ 
demontes the dihedral angle. n is the number of minima on the potential energy function of the 
dihedral angle which defines the periodicity of the bond rotational potential (e.g., n = 3 for sp3 C-
C b  minima. These 
 simulated system. 
 
Non-bonded potentials are usually expressed as a sum over van der Waals (vdW) 
potentials (e.g. expressed in te
  (2.4.3) 
 
The vdW forces describe the attractive and/or repulsive forces between atoms arising 
from permanent or induced dipoles. The Lennard-Jones (LJ) potential, commonly used to 
describe these forces, is expressed in terms of the interatomic distance rij as: 
equilibrium values. Bond rotational, or dihedral angle, potentials, on the other h
bonded atoms, and are conveniently def
ra
Vbonded = ∑bonds Kb(b – b0) + ∑angles Kθ(θ – θ0)  + ∑dihedrals Kψ(1 + cos(nψ 
 
Here, Kb, Kθ, and Kψ are the force constants with units in kcal/mole/Å2
and kcal/mole, respectively; b  and θ  are the equilibrium bond length and bond angle values. 
onds) , and φ is the phase lag parameter, to set the location of these
parameters are defined for all possible groups of atoms that may exist in the
rms of Lennard-Jones function), and Coulombic interactions: 
 
Vnon-bonded = VLennard-Jones + VCoulombic    
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ij ij
interacting atoms, and the summation includes all pairs i and j separated by at least three 
on between two 
or the attractive 
 zero (e.g., at rij  
generally evaluated for pairs of atoms within a certain cutoff distance (8-12Å). Also, it is 
cus  near neighbors 
olecule leads to 
uneven distribution of charge on the molecule, even when the molecule is neutral. Classical FFs 
assign a point charge to each atom based on atoms that are chemically bonded to it. These 
charges do not change during nvironment. Columbic 
potential is used to calculate the energy that arises from these charged interactions: 
 
VCoulombic = 
 
where hard-sphere diameter (σ ) and potential well depth parameter (ε ) depend on the pair of 
intervening bonds. The first term in the LJ potential models the strong repulsi
atoms that arise when their electron clouds overlap. The second accounts f
interactions. The equation has its minimum value at 21/6σij, and quickly decays to
< 10Å) with increasing interatomic distance. For computational efficiency, the LJ potentials are 
tomary to adopt two different sets of parameters, distinguishing between
(separated by 3 bonds) and farther neighbors along the chain. 
 
Differences in the electronegativity of atoms making up an organic m
 a simulation due to varying physical e
∑
−
pairs atom
 bondednon ijD
ji
Coulombic r
qq
K ε        (2.4.5) 
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where q  and q  are partial charges assigned to atoms i and j in fundamental unit of electronic 
sen on distance or 
and the proportionality constant KCoulombic is 322 
kcal*Å/(mol*e2) to express the energy in kcal/mol. 
 
In this work three different molecular mechanics FFs are used. A specific FF for a 
r task is chosen based on the applicability of the force field to that task. When multiple 
force fields are applicable for a certain task, the one that is consistent with prior works of others 
is preferred. 
M FF 
ids (Wang et al., 
kage. It is also 
sed this FF for 
se in small-
molecule docking simulations. The reason that this FF is used is that its parameters and partial 
charges are used in development of molecular docking software, such as AutoDock (Huey et al., 
2007) and DOCK (Meng et al., 1992). Therefore, optimizing the protein structure and assigning 
partial charges using AMBER should result in more consistent scoring of the interactions of 
proteins with small-molecules. 
 
 
i j
charge (e), εD is dielectric constant, whose value may be cho to depend 
medium (e.g. 80 for bulk water), 
particula
AMBER 
AMBER (Assisted Model Building with Energy Refinement) is a popular M
initially developed for performing MD simulations of proteins and nucleic ac
2004; Yang et al., 2006). This FF is part of the AMBER simulation pac
implemented in many molecular modeling packages such as Sybyl. We u
geometry optimization, or energy minimization, of protein structures prior to their u
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CHARMM 
nother MM FF 
l., 2009). It is 
escribed below). 
bination with ANM modes to generate 
alternative structures of target proteins with proper internal geometry. 
mall organic 
Halgren, 1996c; 
Halgren, 1996d; Bush et al., 1999; Halgren, 1999a; Halgren, 1999b). It is implemented in many 
computer aided drug-discovery oriented software packages, such as Sybyl (described below). We 
used MMFF94 to prepare and optimize all small-molecule ligand structures prior to docking 
 
eavy (other than 
odeling purposes. The standard 
procedure in modeling protein-ligand interactions includes adding hydrogen atoms to raw PDB 
structures; placing missing atoms of side-chains or flexible loops of the protein, adding atomic 
partial charges, and optimization of the atomic coordinates based on a force field. We utilized the 
following modeling and simulation packages and their force fields: 
CHARMM (Chemistry at HARvard Macromolecular Mechanics) is a
designed for MD simulations of proteins and nucleic acids (Brooks et a
implemented for convenient use in NAMD (a molecular simulation package d
We used CHARMM implementation in NAMD in com
MMFF94 
MMFF94 (Merck molecular force field) is a FF developed for studies of s
compounds (Halgren & Nachbar, 1996; Halgren, 1996a; Halgren, 1996b; 
simulations. 
2.4.2 Molecular modeling and simulation packages 
The protein structures deposited in the PDB contain coordinates of almost all h
hydrogen) atoms, which is sufficient for many molecular m
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Sybyl 
am from Tripos Sybyl is a commercial industry-standard molecular modeling progr
(http://www.tripos.com/) that has determined many standards in represen
molecules in computer media. We used this software to prepare and energy mi
of proteins and small-molecules. Protein energy minimization was essentially used to optim
All m
tation of small-
nimize structures 
ize 
the positions of the newly added hydrogen atoms, so heavy protein atom positions were fixed. 
inimizations were performed using default method and parameters, except the termination 
criterion. The minimization was terminated when an energy gradient of 0.05 kcal/mol/Å was 
reached. 
5). NAMD can 
in minimization or simulation 
protocols in terms of harmonic restraints on a subset of atoms. This enables deforming a 
structure along global modes. We used NAMD to minimize a protein structure using CHARMM 
force field and ANM restraints. Details of this procedure will be described below. 
When the structure of the protein of interest is not available, but structure(s) of sequentially 
homologous protein(s) are known, comparative modeling techniques may be used to obtain the 
unknown structure based on the known structure(s) and the sequence alignment of the target and 
its template(s). Comparative modeling uses constraints based on the template structures in 
NAMD 
NAMD is a scalable MD simulation package (Phillips et al., 200
incorporate external forces, forces that are not defined in the FF, 
 
2.4.3 Comparative modeling 
 45 
addition to those from all-atom FFs, rotamer libraries and databases of protein structures. The 
al elements of the target 
protein. FFs and rotamer libraries assist in the placement and optimization of side-chains. 
rk, we used two different comparative modeling programs:  
MODELLER 
ftware (Sali & 
R derives spatial 
t model is then 
determined using a variant of the structure determination algorithm developed by Braun and Go 
h 
ultiple models for the target. When we needed a single conformation of 
the target protein, we selected the model with the highest (best) probability score. In cases where 
we needed multiple target conformations, we generated several hundreds of models and used a 
ORCHESTRAR 
re (part of Sybyl 
template structures provide constraints on the fold and secondary structur
 
In this wo
MODELLER is an academically available comparative modeling so
Blundell, 1993). Given sequence alignment and template structures, MODELLE
restraints and expresses them as probability density functions. The targe
(Braun & Go, 1985) which works on the Cartesian space. Due to the random nature of the searc
method, we generated m
subset with the highest scores. 
ORCHESTRAR is commercially available comparative modeling softwa
from Tripos, http://www.tripos.com/) that works on the same basic principles. The advantage of 
ORCHESTRAR is that the user has control over the entire process. The modeling process is 
completely visualized and performed in steps: (i) core backbone structure is modeled, (ii) loops 
are modeled, (iii) side-chains are modeled, (iv) hydrogen atoms are added and structure is energy 
minimized. We used this program when we needed a single model of the target structure. 
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 2.5 ALT MATIONS FROM NORMAL MODE 
GUIDED DISPLACEMENTS 
 in the PDB for 
nformations are 
urface of the target protein by 
enumerating a set of conformations accessible via soft modes, which may be relevant to ligand 
tion to generate 
nimization. The 
implementation of the procedure was analogous to that of ANM restrained MD simulations, 
where a set of harmonic restraints steers the simulation to a target conformation that lies at the 
minimum of the harmonic restraints (Isin et al., 2008). In our case, ANM-based harmonic 
restraints (ANM-HR) were incorporated in energy minimization scheme, using the expression  
 
    (2.5.1) 
 
ERNATIVE PROTEIN CONFOR
Use of alternative protein conformations when docking small molecule ligands improve the 
results (Totrov & Abagyan, 2008). One can find a diverse set of conformations
drug targets only in a few cases. The NMA becomes useful when such co
needed. It helps guide the search on the potential energy s
binding (Cavasotto et al., 2005; Floquet et al., 2006; May & Zacharias, 2008).  
 
In this work, we used the ANM modes with all-atom energy minimiza
alternative conformations for our targets. NAMD was used for energy mi
( )[ ]∑ +−= −− N
i
iiHRANMHRANM sKV
20
ivRR  
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Here, the summation is performed for all α-carbons. R  is the starting position for the ith α-
ent of this mode 
at yields highest 
1 or with a PCA 
t change in 
structure, such as the fluctuations of a binding site loop. If there are multiple relevant ANM 
or any α-carbon. 
rce constant and 
ted that this 
restraint applies to all atoms of a residue. So, the effective force constant per atom is 5 
kcal/(molÅ2), when the average number of heavy atoms per residue is taken to be 8.  
After defining the ANM restraints, the effective potential becomes 
V = V  + V         (2.5.2) 
otential between 
e bending potential for of the 
bonds CH3-CH2-CH3 has a force constant of 53.5 kcal/mol/rad2 (Brooks et al., 2009). ANM 
restraints are therefore considerably softer than those confining bond lengths and bond angles to 
their equilibrium values. The minimization of protein structure subject to Equation 2.5.2 is not 
therefore expected to result in unrealistic distortions in bonded atom geometries. 
i
0
carbon. v is a single or a combined ANM mode. vi is the 3-dimensional compon
corresponding to the ith α-carbon. v may be selected to be the ANM mode th
overlap with a known structural deformation vector according to Equation 2.3.
mode according to equation 2.3.2. It may also be any vector that describes a relevan
modes, they may be linearly combined using the coefficients from Equations 2.3.1 or 2.3.2 to 
yield a combined mode. s is a scaling factor, to set the maximum displacement f
The maximum displacement for an α-carbon was set to be 0.2 Å. KANM is the fo
is set to 40 kcal/mol/Å2. This may seem large for a single atom, but it should be no
 
 
FF ANM-HR
 
 For comparative purposes, the force constant for bond stretching p
carbon atoms of CH3-CH3 is 222.5 kcal/mol/Å2. The bond angl
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 ting from the X-
ing the standard 
ly for the initial 
), but as will 
become obvious in the results section, the slow ANM modes calculated for the unliganded 
Hence, a single 
rposes, as these 
ordinates. When 
generate the conformation along the two opposite directions for each ANM mode. In the 
application of this method to model MKP-3 general acid loop activation, an iterative procedure 
was used to generate conformations along the direction that closes the general acid loop. 
 
 mode of a small 
components: (i) a 
search algorithm that generates multiple binding poses of the small-molecule on the protein 
surface, and (ii) a scoring function that assigns a score to each pose based on pair-wise atomic 
interactions between the small-molecule and the protein. The score is, or scales, with the 
negative of the calculated binding free energy, and either metric, score or energy, will be adopted 
Alternate conformations were generated using an iterative procedure, star
ray structure. At each iteration, the protein was minimized for 200 steps, us
conjugate gradient algorithm in NAMD. ANM calculations were performed on
conformation. It is possible to recalculate ANM modes at each step (Isin et al., 2008
reference structure drive the collective and large magnitude reconfigurations. 
ANM calculation for the initial structure of the protein is sufficient for our pu
collective modes are practically insensitive to the small changes in atomic co
alternative conformations were generated for docking, an iterative procedure was adopted to 
2.6 MOLECULAR DOCKING 
Protein-ligand docking can be defined as computational modeling of the binding
organic compound to a protein (Brooijmans & Kuntz, 2003). This involves two 
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for evaluating binding poses. Different categories of both search methods and scoring functions 
their development have been reviewed in the literature comprehensively (Kitchen et al., 
2004). 
locating potential binding sites for an uncharacterized ligand, and (ii) characterizing optimal 
inte ctions of a ligand at a given binding sites. Two different docking programs are used for 
these purposes as described below. 
ased docking requires to search the entire protein surface for potential binding sites. This is 
an exhaustive search. AutoDock is the preferred software for its ability to efficiently dock 
flex 998; Huey et al., 
2007).  
h method and an 
s a global search 
f GA, the ligand 
corresponds to a gene; the variables that define its state (e.g., translation, orientation, and 
conformation with respect to the protein) form the genotype; and the corresponding Cartesian 
coordinates are the phenotype. Initially, a given number of ligand states (individuals) are 
randomly generated. During the search, randomly selected pairs of individuals are subjected to 
and 
 
In this work, docking simulations have been performed to solve two problems: (i) 
ra
 
2.6.1 Unbiased docking simulations using AutoDock 
Unbi
ible ligands (Goodsell & Olson, 1990; Morris et al., 1996; Morris et al., 1
 
AutoDock uses Lamarckian genetic algorithm (GA) as the primary searc
empirical scoring function as the scoring method (Morris et al., 1998). The GA i
heuristic inspired by evolutionary biology. In the AutoDock implementation o
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crossover to generate a new offspring. Also, a certain fraction of the offspring is subjected to 
 is kept constant 
he length of the 
aximum number 
of generations. Multiple docking runs are in general necessary due to the stochastic and heuristic 
nature of the search. This search method can handle flexible molecules with up to twelve of 
rota
The AutoDock scoring function is an empirical function that predicts binding free energy 
and ding affinity gand. It is form lated as: 
 
∆G  = ∆Gvdw
mutation operation to introduce new traits into the population. The fitness of the individuals is 
determined by the scoring function (Equation 2.4.6). The size of the population
by selecting a predetermined number of individuals based on their fitness. T
search is determined by the maximum number of fitness evaluations or by the m
table bonds. 
 
 thereby the bin  of the li u
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where the ∆G coefficient preceding each term is a scalar that has been c
a training set of 30 protein-ligand complexes with known X-ray structures a
energies. The first tem is the vdW energy term with parameters from the unite
i,j
(2.6.1) 
alibrated against 
nd binding free 
d atom AMBER 
force field (Yang et al., 2006), which implicitly models hydrogen atoms bonded to carbons. The 
second term is a modified LJ potential that provides an improved representation of hydrogen 
bonds. E(t) is a directional weight based on the angle between the hydrogen bond acceptor and 
donor. The third term is the Coulombic potential with a distance-dependent dielectric constant 
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(ε(r )). The fourth term is the ligand torsional entropy term, which adds a constant penalty to the 
 The last term is 
d on atom types 
ted according to 
ost commonly used 
in docking scoring functions (Kitchen et al., 2004). Protein conformational entropy is omitted. 
of MGLTools 
ij
overall score for each rotatable bond that is immobilized upon protein binding.
the solvation term based on pairwise interactions of atoms with parameters base
(V is volume of atoms and S is an atom specific solvation parameter) and weigh
interatomic distance (σ = 3.5 Å) (Morris et al., 1998). These are the terms m
 
In our unbiased simulations we used AutoDockTools, part 
(http://mgltools.scripps.edu/), to prepare input files for energy grid calculations 
set the population size parameter to 250 (default 150), number of maximum fitness evaluations 
and docking. We 
parameter to 5-12 million (default 2.5 million), and number of independent GA runs to 30-200 
(default 10). The remaining parameters were set to the default values (Morris et al., 1998). The 
large number of docking poses generated independently were analyzed using clustering methods 
 
etween a ligand 
s purpose (Jones 
et al., 1997). GOLD also uses a GA as the search method. It yields different types of scoring 
functions. GOLD was chosen as the focused docking software due to its ability to enable side-
chain flexibility during docking. In our simulations, the solvent-accessible side-chains that were 
not involved in specific interactions within the protein were allowed to rotate freely. Protein 
described below. 
2.6.2 Focused docking simulations using GOLD 
Focused (or biased) docking, on the other hand, identify optimal interactions b
and a known binding site of a protein. We used GOLD docking software for thi
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flexibility was introduced by use of multiple protein structures either coming from experiments, 
was particularly 
t for MKPs, as they contain flexible loops and many solvent exposed side-chains at their 
active sites. 
The GOLD fitness function consists of four components: (i) protein-ligand hydrogen 
W), (iii) ligand 
internal torsion). 
utoDock scoring 
ponents are not 
multiplied by any coefficients, so the GOLD scores are not in the same range as typical small-
mo  that the charged 
 
y evaluations) to 
100,000 and GA population size to 100. Since the search space in this case is smaller when 
compared to that of an unbiased docking simulation, the energy evaluation and population size 
parameters were set relatively smaller. The remaining GA-related parameters were kept at their 
default values (Jones et al., 1995). 
 
homology modeling or ANM calculations. Incorporating protein flexibility 
importan
 
bond energy (external H-bond), (ii) protein-ligand vdW energy (external vd
internal vdW energy (internal vdW), and (iv) ligand torsional strain energy (
The total GOLD fitness score is the negative sum of the above terms. Unlike A
function, the scoring function is not fitted to experimental data. That is, the com
lecule binding free energies (-6 kcal/mol to -14 kcal/mol).  Also, please note
interactions are implicitly incorporated into the H-bond term (Jones et al., 1995).
 
When running GOLD, we set the maximum number of operations (energ
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2.6.3 The need for generating large ensembles of docking poses and post-docking 
clustering analysis 
pose for a given 
ctions work best 
when the protein conformation resembles the bound conformation and the search is limited to the 
 
ic effects. It is the task of the user to 
generate multiple protein conformations that can potentially bind the ligand and to incorporate 
entr
 
e experimentally 
 with non-native 
poses (Ruvinsky, 2007). In other words, the bound conformation accommodates slight 
variations in the binding pose without affecting (weakening) protein-ligand interaction energy 
(enthalpy), and this variability, or associated favorable entropy, helps in lowering the free energy 
nergy wells was 
 P450 orthologs 
that process the same substrates (Prasad et al., 2007). These studies provide us with insights into 
how one should select the most likely docking poses. Using molecular docking programs, an 
improved accuracy of predictions could be achieved by clustering analysis of a population of 
docking poses. Thus, it is possible to define various bound ‘states’ (clusters), each comprised of 
The primary aim of docking scoring functions is to find the correct docking 
ligand from amongst many alternative poses at its known binding site. These fun
known binding site (Totrov & Abagyan, 2008). Most docking algorithms and scoring functions
do not account for protein conformational and entrop
opic effects when evaluating docking poses. 
Recently, Ruvinksy showed that the energy well associated with th
observed binding mode of ligands is broader than all energy wells associated
binding 
of binding.  
 
An ensemble modeling approach that takes into account the width of the e
recently adopted to explain the differences in the catalytic rates of cytochrome
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multiple ‘microstates’ (conformations/poses).  The evaluation of the binding energy at each state 
crostates in each 
functions of the 
 to the binding free energy, and the 
entropic contributions scale with the size of the populations of microstates.  
 
und or more than 
 biased docking 
chical clustering 
is not known a priori, and is controlled by a single parameter. Initially, in this scheme, each 
re merged, if the 
 may be defined 
s (one from each 
dinates. We used 
average distance metric and set the threshold to be 2 Å, which is a commonly used threshold to 
cedure consider 
only the heavy atoms of the compounds. In the visual inspection of docking results, we started 
evaluating from the most populated docking pose clusters. In each cluster, we visualized docking 
poses in descending docking score order. We used most populated three to six clusters from 
focused docking simulations to assess or explain the data on the inhibitory action of the ligand. 
can then be based both on the energetic interaction and on the population of mi
state. Indeed the interaction energies, usually accounted for by the scoring 
docking software, simply represent the enthalpic contribution
To account for conformational effects, we generate a large numbers (aro
1000, which is typically 10-100) of docking poses in both unbiased and
simulations and perform cluster analysis of docking poses. Agglomerative hierar
scheme is the preferred method, since it does not require the number of clusters as input, which 
docking pose is considered as a cluster. Iteratively, the closest clusters in space a
distance between them is lower than a threshold. The distance between clusters
to be the average root-mean-square-distance (RMSD) between all pairs of pose
cluster) or as the maximum RMSD between two clusters based on atomic coor
consider two poses of a small-molecule similar. RMSD calculations in this pro
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2.7 SUPPLEMENTARY METHODS 
2.7.1 Electrostatic potential calculations using APBS 
hts into binding 
preferences of the protein (Honig & Nicholls, 1995). Continuum and macroscopic solvent 
odels provide 
lt effect and the 
olecules in polar solvent) by applying two 
different dielectric constants. Visualization tools use programs that provide fast numerical 
solutions of PB equation (Baker et al., 2001; Grant et al., 2001).  
 understand the 
d target proteins. 
., 2001). Protein 
and water dielectric constant values were set to 2 and 78.54, respectively The APBS software 
mat, which contain atomic partial charges 
and radii in addition to coordinates. These input files were prepared using the web server 
http://pdb2pqr-1.wustl.edu/pdb2pqr/
The visualization of electrostatic potentials generated by a protein provides insig
models provide alternate means for explicitly modeling solvent molecules. These m
a solution to the Poisson-Boltzmann (PB) equation (which accounts for the sa
discontinuity of dielectric on the surface of solute m
 
In this work, we used visualization of surface electrostatic potentials to
selective behavior of MKP inhibitors, by comparing surface properties of relate
We performed our calculation using Adaptive PB Solver (APBS) (Baker et al
requires to submit input files for proteins in PQR for
 (Dolinsky et al., 2004). The surface potential was visualized 
using VMD (Humphrey et al., 1996). Color scale data range option was set to show from -10 to 
10. The color scale data range was set from -10 to 10.  
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Programs that provide solutions to PB equation are also used in calculating protein-ligand 
n & Muchmore, 2006). Prospects concerning the 
use of these methods will be discussed in the last section. 
 
rform particular 
binding free energies (Grant et al., 2001; Brow
2.7.2 Scientific programming using Python 
In much of this work, custom Python programming scripts were developed to pe
tasks. Python (http://www.python.org) is a popular programming language 
sciences which is enriched with numerous open-source scientific packages 
the post-docking clustering task described above, 
in computational 
that are readily 
available to perform computational biology tasks. We used Python and such packages to perform 
to glue different modeling and simulation tools 
together by converting the output of one program into an input to another program, or to perform 
numerical calculations such as PCA and ANM. Some of the tasks and the Python packages that 
we benefited from are described below. 
Exploring sequence and structure databases using Biopython 
Biopython (http://biopython.org) is a package containing libraries and functions to 
perform ated searching 
of PDB. X-ray structure datasets of drug targets were assembled using these modules. 
Numerical calculations using Numpy and Scipy 
Scipy and Numpy packages (http://www.scipy.org/SciPy
 common bioinformatics tasks. We benefited from Blast module in autom
) provide easy access to 
powerful libraries to manipulate N-dimensional data arrays. We used Numpy and Scipy objects 
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and functions to manipulate protein coordinate data. Covariance matrices for PCA were 
n matrices were 
performed using a linear algebra module that uses fast LAPACK routine (Anderson et al., 1999). 
The Molecular Modelling Toolkit (http://dirac.cnrs-orleans.fr/MMTK/
calculated using Numpy arrays. Diagonalization of covariance and Hessia
Protein structure manipulation and comparison using MMTK 
) is a package for 
es incredibly convenient to handle protein 
structures with this package. MMTK was used to read structural ensembles, perform iterative 
superimposition, and ANM calculation tasks. 
The similarity between pairs of small-molecules is calculated by comparing their 
 binary arrays. 
l features in the 
ch chemical features may be existence of an element, a certain atom type, a bond 
type, or an organic functional group in the molecule. A predefined set of chemical features are 
used to construct fingerprints for compounds so that each compound has a fingerprint (array) of 
 found in the X-
ray structure datasets were evaluated using the Python implementation of OpenBabel (O'Boyle et 
al., 2008). fingerprint calculations, we used the FP4 option in Pybel, which uses chemical 
patterns defining functional groups. The Tanimoto index was used to measure the similarity 
between two molecular fingerprints, each corresponding to a set of chemical features. The 
molecular simulations (Hinsen, 2000). It becom
Calculation of small-molecule similarity indices using Pybel 
fingerprints (Daylight, 2007). Molecular fingerprints are represented with
Elements of a fingerprint show the absence (0) or existence (1) of chemica
molecule. Su
comparable size.  
 
In this work, the fingerprints and similarities of small-molecule inhibitors
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Tanimoto index is defined as the size of the intersection divided by the size of the union for 
means a pair of 
oto index 0.8 or 
age number of Tanimoto indices lower than 
0.5 for a given set of compounds points to considerable diversity. 
given feature sets. Hence, this index ranges from 0 to 1, and a value of 1 
identical fingerprints. When searching molecular libraries, generally a Tanim
above is used to retrieve similar compounds. An aver
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3.0  THE INTRINSIC DYNAMICS OF ENZYMES PLAYS A DOMIN
 STRUCTURAL CH
ANT ROLE IN 
DETERMINING THE ANGES OBSERVED IN INHIBITOR BOUND 
STRUCTURES 
 
3.1 ANALYSIS OF X-RAY STRUCTURAL ENSEMBLES FOR ENZYMES 
We are interested in understanding the determinants of conformational changes observed in 
drug-bound proteins. To identify a set of targets with multiple structures, we started by 
examining all proteins listed in two publicly available target databases: 
TARGETED BY DRUGS 
 
 
i. The Binding Database (http://www.bindingdb.org/) (Chen et al., 2001) an
ii. DrugBank (
d  
http://www.drugbank.ca/) (Wishart et al., 2008).  
 
From these two databases, we obtained a total of more than 5,000 unique target sequences. For 
each sequence, we searched matching structures in the PDB using automated programming 
scripts (see subsection 2.7.2). For targets with more than 30 structures, we determined whether 
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they were crystallized in complexes with different ligands, inhibitors, or substrates. For targets 
l alignment and 
ets that showed 
 structures), p38 
ase 2 (Cdk2) 
(106 structures, excluding 65 Cyclin bound structures), and cAMP dependent protein kinase (81 
structures). Targets bound to a heterogeneous set of ligands but displaying limited backbone 
var  anhydrase.  
ets, in our study. 
For these three enzymes, we have approximately 300 structures. This large amount of structural 
data permitted us to perform an extensive comparative analysis of the conformational space 
 dynamics of the 
p s we ask are:  
i. How heterogeneous and diverse are the structures of the same protein in different 
ility and ligand diversity, respectively. 
 
ii. Can we describe the heterogeneity in terms of a few dominant modes accessible 
under equilibrium conditions, which can be extracted by PCA of the set of 
structures?  
 
with heterogeneous PDB structure content, we performed automated structura
calculated the RMSD distributions as shown in Figure 3.1. Some of the targ
considerable backbone variability were HIV-1 reverse transcriptase (RT) (112
mitogen-activated protein (MAP) kinase (p38) (74 structures), cyclin-dependent kin
iability included protein tyrosine phosphatase 1B, lysozyme T4, and carbonic
 
We considered RT, p38, and Cdk2, which are widely studied as drug targ
being accessed while binding different ligands, and its relation to the intrinsic
rotein, predicted by the ANM analysis of the unliganded structure. The question
 
complexes? Here, heterogeneity and diversity refer to protein backbone structural 
variab
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iii. To what extent does the protein select from this pre-existing equilibrium when 
d; or to what extent does the particular ligand induce a substrate-
specific rearrangement?  
 
e datasets using 
two common and simple measures. Then, we present PCA and ANM results for each of these 
target proteins. 
3.1.1 ymes 
On the structural variability in the datasets 
SD distributions 
pendix A tables 
SD distributions 
with respect to a reference structure. In each case, the reference structure is chosen to be an 
res are given in respective 
Appendix A tables. Right panels show all-to-all RMSD distributions. Structures in the RT 
ensemble display largest deviations, which is primarily due to the large size of this protein (998 
residues) and the high mobility of its domains. The p38 dataset showed moderate flexibility (354 
residues), and the Cdk2 (298 residues) dataset showed the lowest variability. 
 
binding the ligan
First, we discuss structural variability and small-molecule diversity in th
 
 Structural Ensembles of drug target enz
To display the conformational variability in these datasets, we show RM
in Figure 3.1. The PDB IDs of structures in these ensembles are listed in the Ap
Table A.1, Table A.2, and Table A.3. Left panels in Figure 3.1 show the RM
unliganded form of the protein. PDB IDs of reference structu
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 Figure 3.1 RMSD distributions for three sets of structures: HIV-1 RT, p38 and Cdk2. 
Panels A, B, and C show the RMSD distributions with respect to the respective reference structures for datasets I, II, 
and I.  The Cα RMSDs are based on the residues common to the reference structure and each superimposed 
structure. Panels D, E and F show the RMSD values for all pairs of structures in the dataset, for each member of the 
set indexed (alphabetically ordered according to their PDB identifiers) along the abscissa. Average pairwise RMSD 
values and standard deviations are given in each panel. Figure is adopted from (Bakan & Bahar, 2009). 
 
 
II
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On the diversity of bound inhibitors in the datasets 
 indices over all 
tained total of 59 
 
compounds with an average index of 0.40 ± 0.15. The Cdk2 dataset contained 100 different 
, p38, and Cdk2 
e shown in the 
t conformational 
sites is directly affected by the dominant modes of variability in the dataset (p38 and Cdk2 
hat controls the collective dynamics 
of the target protein (RT dataset). Yet to be answered is whether the binding of the small-
molecule induces these changes or it is the protein that samples those conformations even in the 
absence of the bound small molecules. Our analysis will clarify this issue. 
 
Also notable is the structural diversity of the bound small-molecules in each dataset. To 
show this, we calculated the pairwise similarities by averaging the Tanimoto
pairs of compounds (Figure 3.2; see also subsection 2.7.2). The RT dataset con
different NNRTIs with an average similarity index of 0.37 ± 0.13. The p38 dataset contained 55
compounds with an average index of 0.43 ± 0.14. These values show that RT
datasets contained considerably diverse ensembles of inhibitors. As will b
following subsections, the diversity of bound inhibitors are presumed to effec
variability observed in these datasets for one of these two reasons: (i) the shape of the binding 
datasets), and (ii) the binding site is located at a hinge site t
 
Figure 3.2 Distribution of pair-wise Tanimoto coefficients for inhibitors in X-ray datasets. 
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3.1.2 HIV-1 reverse transcriptase 
1 (Kohlstaedt et 
erase domain is 
ubdomains. The 
connection subdomain links the polymerase and RNase H domains. The p51 subunit bears only 
ifferent tertiary 
lly by interfering 
onal motions of the p66 fingers and thumb upon binding a pocket at a global hinge 
site on the palm subdomain (Kohlstaedt et al., 1992; Bahar et al., 1999; Temiz & Bahar, 2002; 
Zhou et al., 2005).  
nned by the first 
). The points 
therein represent 112 RT structures (see subsection 2.1.3). These two PCA modes were found to 
 provides a clear 
 the types of ligands. ATP bound 
structure is found among the unliganded structures, since ATP binding doesn’t have an affect on 
global shape of the protein. Two unliganded structures are also found among the NNRTI bound 
structures. These structures were obtained after bound NNRTI is soaked out [REF], and shows 
that unliganded RT remains stable in NNRTI bound conformational space. 
HIV-1 RT is a multifunctional enzyme composed of two subunits, p66 and p5
al., 1992). p66 contains the polymerase and RNase H domains. The polym
described as a right-hand containing fingers, palm, thumb, and connection s
the polymerase domain, comprised of the same subdomains, arranged in a d
structure. Non-nucleoside RT inhibitors (NNRTIs) are known to act allosterica
with the functi
 
PCA results 
Figure 3.3A shows the projection of RT structures onto the subspace spa
two principal axes, PC1 and PC2, determined for the examined dataset (Table A.1
account for 71% of the total variance in structure (Equation 2.1.7).  Notably PC1
separation of the structures into three clusters according to
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 Figure 3.3 PCA and ANM results for HIV-1 RT. 
(A) Projection of 6 unliganded (red), 97 NNRTI-bound (blue), 8 dsDNA/RNA-bound (green)
(black) RT structures onto PC1 and PC2. (B) Structural variation along PC1, illustrated usin
, and 1 ATP-bound 
g selected structures 
labeled in panel A. (C) Structural variation along PC2. The inset shows a closer view of the thumb subdomain. 
Inhibitors are shown by the same color as the corresponding RT conformation. In both panels B and C, thumb 
domain moves relatively most, but along orthogonal directions.  (D) Comparison of the weighted sum of square 
displacements along PC1 and PC2, with those along ANM modes 2 and 3 predicted for unliganded reference 
structure. (E) Projections of the 112 structures onto PC1 and ANM2 directions. Standard deviation along this axis is 
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37.2 Å.  (F) Projections onto PC2 and ANM3. Standard deviation along this axis is 26.4 Å. Figure is adopted from 
(Bak  & Bahar, 2009). 
.3B. The most 
tion reveals the 
anti-correlated displacements of the fingers and thumb of about 10Å and 20Å at their most 
 number is the 
cipal axis). Note 
idues. This is a 
strikingly large number, hence is illustrated in Figure 3.4 (see also subsection 2.1.3 for a 
description). The tendency of RT to sample conformations along this mode in the absence of 
ligands is evidenced by site-directed spin labeling experiments (Kensch et al., 2000) and 
supported by ANM (Temiz & Bahar, 2002) and MD simulations (Ivetac & McCammon, 2009). 
 
an
 
The structural variation represented by PC1 is shown in Figure 3
distinctive feature is the large movement of the thumb. More careful examina
exposed regions, respectively. The fluctuations along this mode contribute by 47% to the total 
variance, and span a cumulative displacement of 176Å along this axis (this
difference between coordinates of structures that fall on the extremes of this prin
that this value refers to the cumulative displacement summed over all res
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 Figure 3.4 Projection of conformational changes onto PC1. 
(A) Plot of PC1 (components of the 3N-dimensional vector pk) obtained from the PCA of the RT
the 3N-dimensional conformational change/deformation vector, ΔR1HQE exhibited by 1HQE with
structure in t e ensemble. Note the close similarity between the shapes of p and ΔR1HQE in the res
and B, indicating that the structural difference of 1HQE with respect to the mean structure is alm
by a collective displacement along PC1 (see panel D). This is because PC1 captures the
 dataset. (B) Plot of 
 respect to the mean 
h k pective panels A 
ost fully explained 
 largest magnitude 
differences, and for this dataset unliganded structures show the largest deviation from the mean structure. The 
magnitude ||ΔR1HQE|| of the conformational change vector for 1QHE is 145.9 Å. The RMSD of this structure from 
the mean coordinates is 4.89 Å. (C) Directions of motions along PC1 shown on the average set of coordinates. (D) 
Contribution of different PCA modes to the deformation of 1HQE with respect to the mean structure, represented by 
the projection ci1HQE of ΔR1HQE onto pk. Note that the projection of PC1, c11HQE is considerably large in this case 
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(c1  = 143.3 Å) as the deformation of t1HQE he unliganded structure 1HQE is almost fully along the principal direction 
pk. Figure is adopted from (Bakan & Bahar, 2009). 
es describes the 
e obvious from 
comparisons of arbitrarily chosen structures. These fluctuations are orthogonal to those described 
o structures 
d the polymerase 
rigid body. Motions of thumb domain and 
residues at the tip of polymerase grip are important for polymerase activity. Impairing their 
functional motions and positioning is how NNRTI inhibitors act.  
The PC1 in this 
 of the complete 
ting to note that 
the PC1 from the complete ensemble did not have a strong counterpart in the NNRTI-bound 
subset. This supports the view that NNRTI binding depresses the anti-correlated fluctuations of 
the fingers and thumb, and stimulates thumb fluctuations in an orthogonal direction. This 
observation is in parallel with the previously proposed view that NNRTI inhibition is achieved 
by imparting a change in the direction of the thumb movements (Temiz & Bahar, 2002). 
 
 
 
The second principal mode, PC2, predicted by the PCA of RT structur
out-of-plane fluctuations of the thumb (Figure 3.3C), which would not b
by PC1. Resulting structural differences are illustrated in Figure 3.3C using tw
separated by 81 Å. The inset shows a close up view of the thumb. The thumb an
primer grip (part of the palm) move together as a 
 
As a further test, we performed the PCA of the NNRTI-bound subset. 
case was found to be almost identical (correlation coefficient of 0.99) to the PC2
set, and contributed by 50% to the total variance (Table 3.1). It was also interes
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Table 3.1 Overlap between PCA modes obtained from complete ensembles of reverse transcriptase (RT) structures 
with those  obtain TI bound subed from NNR set of the ensemble 
Subset of NNRTI-bound structures PCA modes 
(fractional contribution PC1 (0.50) PC2 (0.18) PC3 (0.08) ) 
PC1 (0 0  0.50 .47) .07 0.58
PC2 (0.24) 0.99 0.00 0.09 All RT structures 
4 PC3 (0.09) 0.11 0.60 0.5
 
How does a small molecule perturb the global dynamics of such a large structure? The 
ement profile in 
heir positions in 
confirm that the 
 
such constrained regions in the global modes may have a dramatic effect on functional dynamics. 
Yet we not that inhibition of function by blocking a global motion require a druggable binding 
site. The  physicochemical properties 
enables NNRTIs wo
 
Table 3.2 Overlap between PCA and ANM modes for the ensemble of RT structures 
odes ANM1 ANM2 ANM3 
answer lies in the location of the NNRTI binding pocket. As shown in the displac
Figure 3.3D, the binding pocket residues show minimal, if any, variations in t
these two dominant PCA modes. ANM calculations presented below also 
NNRTI binding residues are severely constrained in the global modes of RT. Perturbation of
 special location of NNRTI binding site and its druggable
rk effectively. 
PCA m
PC1 (0.47) 0.25 0.89 0.11 
PC2 (0.24) 0.47 0.08 0.63 HIV-RT 
PC3 (0.09) 0.42 0.06 0.15 
 
Comparison with ANM results 
Figure 3.3D displays the joint effect of ANM modes 2 and 3. These two ANM modes 
were found to yield the highest correlation (among all ANM modes) with PC1 and PC2, 
respectively (see Table 3.2). ANM mode 1, on the other hand, refers to the anticorrelated 
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fluctuations of fingers subdomain and RNase H domain. Comparison with PCA modes showed 
correlation (0.52) with the PC5. The directions of the first three 
ANM modes are shown in Figure 3.5.  
tions induced in 
ANM mode 2 (ANM2), we examined the level of correlation between the projections of the 
lays the results. 
fficient of 0.99), 
observed (PC1) 
we find a correlation coefficient of 0.94, again supporting the view that the most distinctive 
structural changes assumed by the NNRTI-bound RTs simply originate from intrinsically 
favorable ANM modes (Figure 3.3F). 
 
that this mode shows a weak 
 
As a direct comparison of the structural changes along PC1 and the mo
structures onto these two collective displacement directions. Figure 3.3E disp
Strikingly, the structures perfectly align along these two axes (correlation coe
demonstrating the equivalence of the predicted (ANM2) and experimentally 
global modes. Similarly, by projecting the structures onto ANM3, and its PCA counterpart, PC2, 
 
Figure 3.5 Top three ANM modes for reference RT structure. 
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The structure determined by Esnouf et al. (Esnouf et al., 1995) (PDB id: 1RTJ) was used in calcu
diagram displays the intact RT, comprised of subunits p66 and p51. The p51 subunit is not
diagrams as it is almost rigid in those modes.  The p66 subunit domains/subdomains (thum
connection subdomains on the polymerase domain, and the RNase H domain) are shown in di
lations.  The left 
 shown in the right 
b, finger, palm and 
fferent colors (blue, 
red, yellow, orange/brown, green and gray, respectively) for visual clarity. The arrows indicate the directions and 
relat ve sizes of motions predicted in the ANM modes 1 (top), 2 (middle) and 3 (bottom). Figure is adapted from 
(Bak
t together, these results suggest that RT samples conformations pre-disposed to 
NNRTI binding, and NNRTI binding shifts RT dynamics from one mode to another, both being 
intrinsically favored. 
 
rnal stress. They 
regulate the production of proinflammatory cytokines, and hence serve as targets in the treatment 
of inflammatory diseases (Kumar et al., 2003). The structure and interactions of p38s with 
diff tor classes are well characterized. Their dynamics, however, is not well 
understood and poses ch
 
PCA results 
The results from PCA are presented in Figure 3.6. Panel A displays the distribution of 74 
structures of p38 isoform α. The p38 structure has a canonical kinase fold composed of a β-
i
an & Bahar, 2009). 
 
When pu
3.1.3 p38 MAP kinase 
The p38s MAP kinases are serine/threonine kinases activated in response to exte
erent inhibi
allenges in inhibitor design (Cavasotto & Abagyan, 2004).  
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sheets rich N-terminal lobe (N-lobe) and an α-helix rich C-terminal lobe (C-lobe) (Wang et al., 
the cleft between 
ps are displayed in panels B and C to 
illu rate the major structural changes along PC1 and PC2, respectively.  
 
1997). The catalytic site, and also the binding site for competitive inhibitors, is 
these two lobes. Example structures from different subgrou
st
 
Figure 3.6 PCA and ANM results for p38 MAP kinase.  
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(A) Projection of 4 unliganded (red dots), and 56 inhibitor-bound (blue), 10 glucoside-bo
peptide-bound (violet) p38 structures onto PC1 and PC2.  Distant structures along PC1 and
illustrate in the respective panels (B) and (C) the structural variations represented by these PC
lobes are considered in structural alignment for visualization purposes. (D) Square displacement
und (yellow), and 4 
 PC2 are selected to 
s. Note that only C-
s of residues along 
PC1 and PC2, compared to those driven by ANM modes 1 and 3. (E) Projections of the 74 structures onto PC1 and 
ANM3. (F) Projections onto PC2 and ANM1. Figure is adopted from (Bakan & Bahar, 2009). 
 
shown by the 
n panel B. These 
(panel A). PC2, on the other hand, involves twisting motion of N-lobe with respect to the C-lobe 
e of the motions 
e (Cα) changes 
ugh these modes 
egrees of freedom out of a total of 963, they account for 45% of the variance in 
the backbone structure observed in the dataset (Table 3.3), and reconfigurations along these two 
directions allow for he averag D e  the mean structure from 1.0 ± 
0.3 Å to 0.53 ± 0.17 Å. 
 
Table 3.3 Overlap between PCA and ANM modes for the ensemble of p38 structures 
PCA modes ANM1 ANM2 ANM3 
 
PC1 refers to anti-correlated movements of the two lobes, as 
superimposition of an unliganded (red) and an inhibitor-bound (blue) structure i
movements map to a separation of more than 25 Å between the two conformers along PC1 axis 
illustrated by a glucoside- and an inhibitor-bound structure (panel C). The siz
along PC2 is comparable to that along PC1 (panel A). The global backbon
observed in the ensemble are well described by the first two PCs. Notably, altho
represent only 2 d
 reducing t e RMS  with r spect to
PC1 (0.29) 0.39 0.05 0.71 
PC2 (0.16) 0.79 0.21 0.22 p38 
PC3 (0.11) 0.06 0.57 0.05 
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  the unliganded 
ion and optimal 
eft increases the 
complexed with its primary substrate MAPK-activated protein kinase 2 (MK2), which is located 
). Other peptide-
sites of p38 
mational change 
hite et al., 2007). 
These show that movements captured by PC1 are functionally relevant. Fluctuations along PC2, 
on the other hand, change the rela een the lobes, 
om the weighted 
contributions of movements along PC1 and PC2. The binding pocket residues are marked by the 
ely 
f inhibitors may 
odes. The average 
pairwise similarity among the 55 compounds in the dataset is 0.40 ± 0.15 based on standard 
cheminformatics metrics. Apparently, the movements of the lobes allow for optimizing their 
interactions with the small-molecules, and hence the poor results in in silico cross-docking 
experiments, when the target backbone is assumed to be rigid (Cavasotto & Abagyan, 2004). 
Fluctuations along PC1 determine the exposure of the binding cleft. In
state, the cleft is wide open, presumably to facilitate ATP/inhibitor recognit
interaction. Upon ligand binding the cleft closes down. The closure of the cl
packing interactions with the bound molecule. In one of the peptide-bound structures, p38 is 
20Å away from the unliganded p38 along PC1 (labeled as 2OZA in Figure 3.6A
bound structures contain short stretches, corresponding to docking 
regulators/substrates, with comparably much less impact on p38. The confor
observed when p38 is crystallized with MK2 potentially affects its function (W
tive positioning of the atoms lining the cleft betw
affecting in particular the β-strands 1 to 3 and the connecting hairpins.  
 
Figure 3.6D displays the square displacements of residues resulting fr
blue dots. Some of them, corresponding to hinge sites in these global modes, are extrem
constrained, and others show moderate displacement. The structural diversity o
be a primary reason for the conformational heterogeneity along these m
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 anking three PC 
to be ANM3 and 
ANM1, with respective correlation coefficients of 0.71 and 0.79. ANM2, a twisting motion of 
 illustrates 
des 1 and 3 are 
les agree with a 
 ANM-predicted 
fluctuations. Hence, we projected the ensemble onto these ANM modes and distributions along 
Figure 3.6E) and PC2-
orrelation coefficients of 0.95 and 0.82, respectively. This 
excellent correspondence underscores the robustness of the low-frequency modes, and shows 
their functional importance in accommodating the binding of structurally diverse inhibitors as 
well as the cellular protein substrate MK2. 
 
Comparison with ANM results 
The correlations between the lowest three ANM modes and the top-r
directions are listed in Table 3.3. The counterparts of PC1 and PC2 are found 
the two lobes, was found to correspond to PC3 with a coefficient 0.57 (Figure 3.7
these three ANM modes). The displacements of residues induced by ANM mo
compared in Figure 3.6D with those driven by PC1 and PC2. The two profi
correlation coefficient of 0.79. Also important is the directionality of
corresponding PCs. Distributions of the structures along the PC1-ANM3 (
ANM1 (Figure 3.6F) yielded c
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 Figure 3.7 Top three ANM modes for reference p38 structure. 
Calc ations were performed using the structure determined by Wang et al. (Wang et al., 1997) (PDB id: 1P38). The 
central small-molecule, shown in space-filling, was not included in the calculations, but displayed in the figure to 
illustrate the ligand binding site. Figure is adapted from (Bakan & Bahar, 2009). 
Cdks are serine/threonine kinases involved in the regulation and progression of the cell cycle. 
Cdk activity is regulated by activator (cyclin family) or inhibitor (INK and Cip families) protein 
binding and phosphorylation (Pavletich, 1999). In cyclin- or Ink-bound structures, the N-lobe 
adopts a host of distinct conformations intrinsically favored by Cdk (Tobi & Bahar, 2005). This 
ul
 
3.1.4 Cyclin-dependent kinase 2 
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conformational flexibility impacts the ATP/small-molecule pocket, and hence needs to be 
considered in designing drugs (Cavasotto & Abagyan, 2004). 
 
 
Figure 3.8 PCA and ANM results for Cdk2.  
(A) Projection of 2 unliganded (red), 3 ATP-bound (green), and 101 inhibitor-bound (blue) Cdk2 structures onto 
PC1 and PC2. (B) Structural variation along PC1. Note that only C-lobes are considered in structural alignment for 
visualization purposes. (C) Structural variation along PC2. (D) Comparison of the square displacements of residues 
alon  PC1 and ANM2. (E) Projection of 106 Cdk2 structures onto PC1 and ANM2. Figure is adopted from (Bakan 
& Bahar, 2009). 
 
 
 
g
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Results from PCA 
owly distributed 
h respect to the 
ot be large and 
able to account for 39% of the variance in the dataset (Table 3.4). The projection of Cdk2 
istinguishing the 
r at a distinctive 
 extremes of this 
describes the twisting motion of N- and C-lobes, which is comparable to p38 movements along 
Figure 3.8B). In 
ordinate, which 
 described by the 
C illustrates such 
a local movement for the so-called glycine loop that lines the binding cleft. The two structures in 
this panel are 10.8 Å apart when projected onto PC2. The heterogeneity of the ensemble along 
these modes presumably originates from the physicochemical diversity of bound inhibitors. The 
ensemble contained 100 different compounds with an average pairwise similarity metric of 0.43 
± 0.14. 
 
 
We have assembled a set of 106 Cdk2 structures. This set was more narr
compared to the previous two cases (average RMSD of 0.50 ± 0.14 Å wit
reference structure; Figure 3.1) and therefore the structural variations may n
precise enough to classify them into distinctive PC modes. Yet, the first two PCA modes were 
structures onto PC1 and PC2 showed a diffuse distribution, not clearly d
different bound forms, although the two unliganded structures clustered togethe
end of the subspace (Figure 3.8). We selected the Cdk2 structures that fall in the
distribution to visualize the conformational differences along these two PCA directions. PC1 
PC2. This is illustrated by two structures that are 13.2 Å apart along this axis (
Figure 3.8A, the unliganded structures fall close to the center on PC1 co
indicates that twisting motion occurs in either direction. The structural variation
PC2, on the other hand, was localized at chain termini and flexible loops. Panel 
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Table 3.4 ween PCA a  m r t ble of Cdk2 structures 
PCA modes 1 M2 ANM3 
Overlap bet nd ANM odes fo he ensem
ANM AN
PC1 ) 6 .73 0.09  (0.23 0.3 0
PC2 (0.16) 0.06 0.05 0.26 Cdk2 
PC3 (0.12) 0.48 0.09 0.34 
 
Comparison with ANM predictions 
The top ranking ANM modes predicted for the unliganded structure (1HC
displayed in 
L) are 
PC1 (Table 3.4). 
e 3.8D. Some of 
 
in highly mobile regions of N-lobe. Those at the minima include Val64, Phe80, Asn132 and 
Ala144-Asp145, which are buried deep into the cleft between the two lobes, while those 
is indicates that 
ues, while other 
 for the catalytic 
ensemble of structures onto ANM2 and PC1 yield a correlation of 0.97 (panel E). These suggest 
that despite the minimal changes in structure, the observed structural heterogeneity is not 
random, but geared towards the intrinsically favored mode of motion. The changes along the 
experimentally observed PC2, however, seem to be rather local and would rather be viewed as 
induced by inhibitor binding. 
 
Figure 3.9. Among them, ANM2 yields a correlation of 0.73 with 
The square displacements of residues along these modes are compared in Figur
the binding pocket residues are located at the minima of these profiles, while the rest are located
exhibiting moderate-to-high flexibility are at the periphery of the cleft. Th
fluctuations along this mode allow for the positioning of recognition site resid
functional residues, such as Asn132 and Asp145 that coordinate the metal atom
reaction, and the catalytic residues Asp127 and Lys129 are almost fixed. The projections of the 
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 Figure 3.9 Top three ANM modes for reference Cdk2 structure. 
ANM calculations were performed for the structure resolved by Schulze-Gahmen et al. (Schulze-Gahmen et al., 
1995) (PDB id: 1HCL). A small molecule (not included in the calculations) is shown in space filling representation 
to indicate the ligand binding site. Figure is adapted from (Bakan & Bahar, 2009). 
 
H ANM 
tically favorable, 
mechanisms/modes of structural rearrangements along preferential mode axes; and the ligand 
selects the one that best matches its structural and dynamic properties. Yet, this may mean that 
the ligand may be able to induce observed collective conformal changes, since they are along 
low-energy mode directions. If we are able to show that these low-energy modes do also describe 
3.2 SOLUTION DYNAMICS OF PROTEINS COMPARED WIT
So far, we showed that the protein topology offers a few well-defined, energe
 81 
the solution dynamics of proteins in the absence of ligands, this will unambiguously demonstrate 
nges, but selects 
of the ligand. To 
iquitin (Lange et 
distributions for these two ensembles. Our analysis confirmed that the conformational space 
sam roteins in solution, in the absence of ligand, is consistent with ANM-predicted 
global modes, as will be presented in details in this section. 
 
 
that the bound small-molecule does not induce the observed conformational cha
from a set of conformations that are sampled by the protein even in the absence 
explore this, we analyzed broad ensembles of NMR models determined for ub
al., 2008) and calmodulin (CaM) (Gsponer et al., 2008). In Figure 3.10, we display the RMSD 
pled by these p
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 Figure 3.10 RMSD distributions for three ensembles of NMR mod
chain kinase (MLCK). Panels A, B and C show the RMSD distributions with respect to the re
each set (respective PDB codes: 2K39, 2K0E and 2K0F). The number of NMR models in each e
in th
els. 
Ensembles belong to ubiquitin, calmodulin, and calmodulin complexed with a 19-residue peptide from myosin light 
ference structures in 
nsemble is indicated 
e panels. Panels D, E and F show the pairwise RMSD values with respect to all other models in the ensemble 
for each model (indexed along the ordinate), similar to panels D-F of Figure 3.1. The model indices along the 
abscissa correspond to those assigned in the respective PDB files. Average RMSD values and standard deviations 
are given in each panel. The results for ubiquitin refer to residues 1-70, excluding the disordered 6 residues at the C-
terminus. Note the broad distribution in RMSDs for CaM (panels B and E). Figure is adopted from (Bakan & Bahar, 
2009). 
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 08) and for CaM 
parable to those 
odes of structural 
change extracted from the PCA of these ensembles correlate with those predicted by the ANM? 
 
ls onto PC1 and 
M global modes.  
ed form (Figure 
lix that is readily 
flexed. We examined the principal modes accessible to the NTD and CTD in relation to their 
ts, as a further comparison. Correlations in the range 87% to 94% were 
observed in both cases (Figure 3.12, panels A-D), demonstrating that the ANM provides a good 
rep ed that they are 
 
ht chain kinase 
MR models are 
in accord with ANM predictions (correlations of 0.88 and 0.77 in Figure 3.12 panels E-F). The 
results for all examined NMR ensembles are compiled in Table 3.5 and Table 3.6, and 
illustrated in Figure 3.13. The cumulative overlaps between subsets of 3, 6, and 20 ANM modes 
with the top three PCs (Table 3.6) further support the consistent correlation between the 
The ensembles of NMR models deposited for ubiquitin (Lange et al., 20
(Gsponer et al., 2008)  have been pointed out to sample conformations com
observed in their substrate-bound forms. The question is: how do principal m
Results are presented in Figure 3.11. The projection of the NMR mode
PC2 are shown in both cases to exhibit a close agreement with one or two AN
We note that CaM samples a very broad conformational space in its unligand
3.13) as the N- and C-terminal domains (NTD and CTD) are connected by a he
ANM counterpar
resentation of the variability of the structures even within domains, provid
sufficiently decoupled. 
Finally, we also analyzed the complex CaM-MLCK with a myosin lig
(MLCK) peptide, which further confirmed that principal modes derived from N
 84 
subspace of conformations seen in the experimental structures and those predicted by 
com
 
putations.   
 
Figure 3.11 Comparison of the PC and ANM modes for ubiquitin and CaM ensembles. 
The projections of NMR models for ubiquitin (panels A and B), and CaM (C and D) onto PC1 and PC2 are 
compared with the projections onto ANM global modes. ANM calculations are performed for the model that has the 
lowest RMSD with respect to all others in each ensemble. Figure is adopted from (Bakan & Bahar, 2009). 
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 Figure 3.12 Comparison of the PC and ANM modes for CaM ensembles.
Projections of NMR ensemble onto PCA modes 1 and 2 are compared with projections onto A
for CaM-NTD (panels A and B), CaM-CTD (panels C and D), and CaM-MLCK (panels E an
 
NM modes 1 and 2, 
d F).  Residues 5-79 
and residues 83-147 were considered for the respective NTD and CTD, respectively. ANM calculations were 
performed for a representative model (the one with the lowest RMSD from all others) in each ensemble. The 
corresponding models numbers are 101, 1, and 21 for CaM-NTD, CaM-CTD, and CaM-CLMK, respectively. Figure 
is adopted from (Bakan & Bahar, 2009). 
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 T rlap betwee nd o MR ensembles 
PCA modes 1 M2 ANM3 
able 3.5 Ove n PCA a  ANM m des for N
ANM  AN
PC1 ) 9 .30 0.62*  (0.13 0.1 0
PC2 ) 9 .72 0.16*  (0.09 0.0 0Ubiquit
3 ) 1 .06 0.00* 
in 
PC  (0.08 0.3 0
PC1 ) 4 .54 0.30  (0.31 0.5 0
PC2 ) 1 .49 0.17  (0.25 0.7 0CaM
3 ) 5 .54 0.57 
 
PC  (0.20 0.0 0
PC1 ) 2 .37 0.12  (0.18 0.7 0
PC2 ) 1 .75 0.15  (0.10 0.2 0CaM-ML
3 ) 7 .28 0.43 
CK 
PC  (0.09 0.3 0
PC1 ) 9 .70 0.48  (0.25 0.2 0
PC2 ) 1 .18 0.23  (0.21 0.9 0CaM-NT
.05 0.03 0.09 
D 
PC3 (0.12) 0
PC1 (0.51) 0.61 0.13 0.17 
PC2 (0.14) 0.32 0.70 0.02 CaM-CTD 
PC3 (0.08) 0.16 0.28 0.29 
* Overlap values for ANM mode 4. 
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 Figure 3.13 Directions of PCA modes and corresponding ANM modes. 
Ubiquitin (A), CaM (B), CaM-NTD (C), CaM-CTD (D) and CaM-MLCK (E). The structures are shown in cartoon 
representation and colored according to residue index from red (N terminus) to blue (C-terminus). Figure is adopted 
from (Bakan & Bahar, 2009). 
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3.3 DISCUSSION 
 
s experimentally 
dicted by simple 
physics-based models based on their native fold contact topology. In all three cases, the first 
its a correlation 
ally preferred by 
of PC and ANM 
f 0.85 ± 0.06 by 
the top three ANM modes in all three cases. Similarly, the principal modes of structural 
variab
of the structural 
variance observed in the datasets of enzymes. The structures display further heterogeneities 
beyond those along the first three PCs,
 target proteins’ 
 
The top ranking ANM modes are by definition collective modes of motions, and they are 
also known to be highly robust against sequence and structure variations. The strong correlation 
of experimentally observed structural changes with these ANM modes demonstrates the 
We presented here a detailed analysis of the conformational change
observed for three enzymes upon binding a broad range of ligands, and those pre
principal mode of structural change, PC1, derived from experimental data exhib
of 0.78 ± 0.1 with a top-ranking mode (ANM1-ANM3) predicted to be intrinsic
the (unliganded) protein. If, we further consider the correlation between subsets 
modes (Table 3.6), we see that PC1 is accounted for with a cumulative overlap o
ility observed in NMR ensembles exhibited remarkable correlations with top-ranking 
ANM modes. 
 
We note that three PCs describe between 50% (Cdk2) and 80% (RT) 
 specific to particular inhibitors, which would rather fall in 
the category of induced changes, succeeding the initial recognition driven by
intrinsic dynamics, as ilustrated in Figure 3.14. 
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collectivity and robustness of the structural changes undergone by these enzymes upon binding 
their ligands, even if the sizes of these concerted motions are small in many cases. 
 
Table
m ve overlap 
 3.6 Cum ive rlaulat  Ove p 
  Cu ulati
  PC1 PC2 PC3 3 PCs 
3 ANM d .93 0.79 0.45 0.75  mo es 0
6 ANM d .95 0.82 0.84 0.81  mo es 0HIV
M d .96 0.89 0.83 0.89 
-RT 
20 AN  mo es 0
3 ANM d .81 0.84 0.57 0.75  mo es 0
6 ANM d .83 0.85 0.65 0.78  mo es 0p38 
20 ANM d .89 0.87 0.76 0.84  mo es 0
3 ANM d .82 0.27 0.59 0.60  mo es 0
6 ANM d .87 0.33 0.65 0.66  mo es 0Cdk2 
20 ANM d .93 0.46 0.85 0.77  mo es 0
3 ANM d .42 0.75 0.39 0.54  mo es 0
6 ANM d .75 0.80 0.53 0.71  mo es 0Ubiqu
M d .85 0.84 0.70 0.80 
itin 
20 AN  mo es 0
3 ANM d .81 0.88 0.78 0.83  mo es 0
6 ANM d .82 0.90 0.86 0.86  mo es 0C
M d .84 0.93 0.89 0.89 
aM 
20 AN  mo es 0
3 ANM d .82 0.80 0.63 0.75  mo es 0
6 ANM d .86 0.82 0.78 0.82  mo es 0CaM-ML
M d .94 0.90 0.91 0.92 
CK 
20 AN  mo es 0
3 ANM modes 0.90 0.95 0.11 0.76 
6 ANM modes 0.91 0.96 0.57 0.83 CaM-NTD 
20 ANM modes 0.93 0.97 0.72 0.88 
3 ANM modes 0.65 0.77 0.44 0.63 
6 ANM modes 0.69 0.80 0.49 0.67 CaM-CTD 
20 ANM modes 0.77 0.83 0.62 0.74 
Above values are calculated using Equations 2.3.4 and 2.3.5. 
 
What is the physical basis of ANM modes? These modes are purely based on native 
contact topology, or geometry. No specific interactions, other than the absence/presence of inter-
residue contacts (equivalent to an excluded volume effect) are taken into consideration. The 
basic driving potential is entropic in origin, i.e., the directions of motions predicted by the ANM 
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are those entropically favored, where the uphill curvature away from the original energy 
ed deformations 
t the conformational changes undergone for ligand binding are dominated by 
entropic effects. 
 
minimum is minimal. The close correspondence with experimentally observ
suggests tha
 
Figure 3.14 Schematic description of observed mechanism. 
Inhi protein. This first 
nce. The structural 
ic ligands. 
 
On a practical side, the fact that the structures assumed by the target proteins for 
recognizing their substrates comply with the global modes of motions ‘predictable’ by simple 
models such as the ANM opens the way to possible generation of representative ensembles of 
bitor recognition and early binding events are dominated by the intrinsic dynamics of the 
group of rearrangements account for 50-80% of the experimentally observed structural varia
heterogeneities beyond those accounted for by top ranking PCs (or ANMs) are induced by specif
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conformers with the ANM. Adequate consideration of target proteins’ backbone flexibility has 
as been to dock 
Abagyan, 2008). 
5), or, ensembles 
may provide incomplete, if not inaccurate, information. The absence of a PCA counterpart for 
hortcomings are 
ein (Levin et al., 
 deposited in the 
ental (and semi-
empirical) constraints, or physically accessible conformations - is yet to be established (Best et 
cted from NMR 
with present observations for ubiquitin and CaM, and 
with the structural variations observed in X-ray structures (Tobi & Bahar, 2005; Yang et al., 
2008) are in support of the use of ANM for consolidating existing structural data, or gaining 
insights into potential inhibitor binding mechanisms. 
been a major bottleneck in computer-aided drug design. A proposed solution h
ligands onto multiple receptor conformations (ensemble docking) (Totrov & 
Sets of crystal structures, each bound to a distinct ligand (Barril & Morley, 200
of NMR structures (Huang & Zou, 2007) have been considered to this aim. However, both sets 
the ANM1s predicted for RT or for Cdk2 may signal such deficiencies. Such s
likely to be alleviated by resolving multiple X-ray structures for a given prot
2007). As to NMR structures, the physical meaning of the ensemble of models
PDB - whether they represent a ‘mathematical solution’ that satisfies experim
al., 2006). The correlations of the global ANM modes with the PCA modes extra
ensembles (Yang et al., 2009), consistent 
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4.0  TARGETING MAP KINASE PHOSPHATASES (MKPS): INSIGTS FROM 
STRUCTURE-BASED MODELING OF INHIBITOR INTERACTIONS 
 
4.1 INTRODUCTION 
 
MKPs vary in length from 180 to 660 amino acids and all possess a canonical tyrosine 
inal 
ty.  
A list of MKP catalytic domain structures resolved to date is given in Table 4.1. These 
MKPs share at least 40% sequence identity with respect to the catalytic domains of MKP-1 and 
MKP-3 (Table 4.1), in which we are particularly interested. Selected structures are shown in 
Figure 4.1, and their sequence alignments are presented in Figure 4.2.  
 
4.1.1 Sequence, Structure, and Function 
phosphatase domain (Farooq & Zhou, 2004). Most of the members also possess an N-term
substrate binding domain (BD) that facilitates substrate recognition and specifici
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Table 4.1 MKP catal ntities. 
 t m t s % e ong MKPs * 
ytic domain structures and their sequence ide
Ca alytic do ain  s ructure   pairwise sequence id ntity am
Name PDB I Res. Å) ate P K PAC-1 VH3 D ( St MK -1 M P-3 MKP-4 MKP-5 
MKP-1 – – – .2 46 73.97 64.38 – 47 6 .58 41.78 
MKP K ve .0 – 8 47.95 43.84 -3 1M P 2.35 Inacti 58 6 0.14 47.26 
MKP 2HX e .8 . – 47.95 43.84 -4 P 1.83 Activ 54 4 96 77  46.58 
MKP 1ZZ e .8 . 5  42.47 34.93 -5 W 1.60 Activ 54 4 54 84 8.06 –
PAC-1 1M3G NMR Inactive 77.42 51.61 48.39 48.39 – 57.53 
VH3 2G6Z 2.70 Active 70.97 48.39 45.16 41.94 58.06 – 
* Upper triangular entries refer to the sequence identity percentages at the catalytic domains; lower triangular entries 
to th se at the active site region of the catalytic domain. The corresponding multiple sequence alignment is given in 
Figure 4.2. 
 
o
 
Figure 4.1 MKP CD domain structures in active and inactive states. 
The active site loops display substantial changes between active and inactive states. General acid loops are marked 
with an asterisk. Coloring is according to the sequence alignment shown in Figure 4.2. Figure is adopted from 
(Bakan et al., 2008). 
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 ded β-sheet (six 
one side and one 
te  of the PTPase 
active PTPase loop conformation upon binding their substrates. On the other hand, MKP-5 
te PTPase loop 
c ability of some 
mations that facilitate ligand binding even in the unbound state (Bahar 
et al., 2007). In addition, BD structures of MKP-3 (Farooq et al., 2001) and MKP-5 (Tao & 
Tong, 2007) have been resolved. 
hich the general 
 its inactive configuration (Figure 4.2) will be referred to as inactive, low-activity 
or basal-activity state. The state in which general acid loop is at activated configuration (where it 
participates in the dephosphorylation reaction; Figure 4.2) will be referred to as activated or 
 
 
inhibition mechanisms 
Substrate recognition is achieved by the BD of MKPs. In the case of MKP-1 (Hutter et al., 
2000), MKP-3 (Camps et al., 1998), and PAC-1 (Zhang et al., 2005), the allosterically bound 
MKP catalytic domains share the same fold with PTPs, - a five stran
stranded in the inactive state of PTPase loop) surrounded by four α-helices on 
α-helix on the other Figure 4.1. The MKP structures resolved in the inactive sta
loop, MKP-3 (Stewart et al., 1999) and PAC-1 (Farooq et al., 2003), are known to adopt the 
(Jeong et al., 2006) and VH3 (Jeong et al., 2007) adopt the active sta
conformation even in the absence of bound substrate, consistent with the intrinsi
enzymes to sample confor
 
In the remainder of this section, the state of MKP catalytic domain in w
acid loop is at
high-activity state.
4.1.2 Catalytic activation of MKPs upon substrate recognition offers alternative 
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substrate triggers the catalytic activation of the phosphatase accompanied by a movement of 
es two potential 
 binding to 
ion. The second 
itory action 
has been achieved for PTP1B via the restriction of a catalytically important loop from adopting 
an a 04).  
 addition to the 
plexed with the 
kinase interaction motif from MKP-3 BD has been determined (Liu et al., 2006). The specific 
ic mutation and 
/D exchange experiments 
(Zhou et al., 2006) have been used to construct a structural model of the MKP-3/ERK2 complex. 
All of these data suggest that a further examination of the binding surface and dynamics of 
MKP-3 is warranted and could assist in identifying novel sites for enzyme inhibition. 
 
about 5 Å in the acidic loop (Figure 4.1). This geometric adjustment provid
inhibition mechanisms as alternatives to the conventional mechanism of competitive
the catalytic site. The first would involve the inhibition of substrate recognit
would target the obstruction of the allosteric mechanism of activation. Such an inhib
ctive state conformation upon binding a small molecule (Wiesmann et al., 20
 
We note that MKP-3 preferentially dephosphorylates ERK2, and in
resolved structures of the catalytic domain and BD, a structure of ERK2 com
regions of MKP-3 that interact with ERK2 have been elucidated in systemat
deletion analyses (Zhou et al., 2001); and finally the results from H
 
Figure 4.2 Alignment of MKP catalytic domain sequences. 
Figure is adopted from (Bakan et al., 2008). 
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 4.2 MKP-1/INHIBITOR INTERACTIONS 
4.2.1 Structurally unique inhibitors of MKP-1 from a focus library of pyrrole 
terrogation of its 
ory to employ a 
recently described tricyclic pyrrole-2-carboxamide library in their screening efforts (Werner et 
 the pyrrole 
P-1 (Lazo et al., 
specially notable 
alue (inhibitor 
, is inhibited) of 
8.0 ± 0.9 µM.  It showed some selectivity for MKP-1 over the closely related phosphatases 
ined the surface 
inhibited MKP-1 
sphatase inhibition was retained in the presence of 
physiologically relevant concentrations of glutathione, - an antioxidant that quenches formation 
of reactive oxygen species used to show/verify that the inhibitors do not act through oxidation of 
catalytic cysteine.  We performed detailed molecular docking studies of PSI2106 to identify key 
side-chains playing a role in binding these compounds. 
carboxamides 
The lack of readily available selective MKP-1 inhibitors has severely limited in
biological role and was one rationale for our collaborators in Dr. Lazo Laborat
al., 2006). In our joint report, we demonstrated the pharmacological richness of
carboxamide library by finding that 10 of 172 members inhibited human MK
2007). One of the pyrrole carboxamides, PSI2106 (shown in Figure 4.3), was e
in vitro inhibitors of recombinant human MKP-1 enzyme activity with IC50 v
concentration at which 50% of the enzyme activity, with respect to its maximum
MKP-3, Cdc25B, VHR, and PTP1B.  To understand this behavior we exam
properties near the catalytic site of the studied phosphatases.  The compounds 
reversibly but displayed mixed kinetics. Pho
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Figure 4.3 MKP-1 inhibitor from a focused pyrrole carboxamide library. 
Note the comparable activities (IC50 values) of this compound against MKP-1 and MKP-3. Figure is adopted from 
 
4.2.2 Basis of specificity of inhibitors from electrostatic surface potential calculations 
rface 
P-1 and MKP-3 
ticular there was 
a concave region surrounded by hydrophobic residues on both structures, where the hydrophobic 
groups of the compounds tended to be positioned. Cdc25B and VHR, on the other hand, 
exhibited a significantly more polar/charged character near the catalytic site. Cdc25B active site 
was essentially basic, while VHR showed mostly acidic and some hydrophobic character. We 
(Bakan et al., 2008). 
To assist in understanding the potential specificity of PSI2106, we examined the su
properties of the catalytic domains of the four phosphatases (Figure 4.4).  MK
displayed similar surface properties in the neighborhood of the active site. In par
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then conducted unbiased molecular docking simulations in which the 10 active compounds were 
sing AutoDock 
tiomers of each 
 of all poses are 
olecules cluster. 
Notably, at least three potential binding sites were predicted for the ten active compounds, one of 
them being near the catalytic cysteine and are seen enclosed in the blue ellipse.  
 
docked without any pre-defined binding site to the four protein phosphatases u
(Morris et al., 1998). Thirty docking runs were performed for both enan
compound, leading to a total of 600 poses for each phosphatase. The centroids
displayed in Figure 4.4 to identify potential binding sites where the small m
 
Figure 4.4 Surface properties of dual-specificity phosphatases (DSPs) and potential inhibitor binding sites. 
The surface representations are colored based on solvent-exposed surface electrostatic potential calculated using 
APBS (Baker et al., 2001). Red and blue correspond to negatively and positively charged (or polar) regions, 
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respectively; and white refers to neutral (or hydrophobic) regions.  Each dot corresponds to the 
pose for a compound and there are 600 hundred poses for each phosphatase. Catalytic cavities ar
The clusters in the neighborhood of the catalytic sites are colored yellow and encircled in blu
second and third most distinctive clusters are shown in red and gray, respectively. Note th
centroid of a binding 
e encircled in white. 
e. The poses in the 
e difference in the 
polarity/hydrophobicity of the surface within the blue circles, pointing to the origin of the differences in the 
selectivity of the small molecules against these DSPs. The diagrams were generated using VMD (Humphrey et al., 
1996
e cavities on the 
e and colored 
roposed to form 
the bound conformations that can potentially exhibit competitive inhibition.  Based on the 
comparative analysis of these binding surfaces in the four DSPs, we reasoned that the greater 
inhibitory action of the ten compounds for MKP-1 and MKP-3 might be associated with the 
 
 binding site of 
 combination of 
comparative modeling (MODELLER) (Sali & Blundell, 1993), structure refinement (Sybyl 7.2; 
Tripos, Inc. St. Louis, MO), and docking tools (GOLD) (Jones et al., 1995; Jones et al., 1997). 
Using the catalytic domain structures of MKPs in the active state listed in Table 4.1, we 
generated 300 models (conformations) of MKP-1. The objective was to take into consideration 
). Figure is adopted from (Lazo et al., 2007). 
 
Docking poses were found to cluster at hydrophobic regions and larg
surface. Clusters were determined using agglomerative clustering schem
differently. The poses closest to catalytic sites are shown in yellow. These are p
hydrophobic nature of the surface near their active site.  
4.2.3 Interactions of MKP-1 with pyrrole carboxamides 
We further performed targeted (or biased) docking simulations in the putative
MKP-1. Results from ensemble modeling of interactions were obtained using a
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the possible structural flexibility (and/or inaccuracy) of the modeled target proteins (encircled 
times onto each 
 ensemble of 
d the role of the 
 
inhibitor (Figure 4.5). In addition, a number of hydrophobic contacts involving residues Ala260, 
nteractions were 
cked this type of hydrophobic 
interactions.  These residues presumably mediate the binding of pyrrole carboxamide inhibitors 
in favor of a geometry that occludes the access of substrates to the catalytic site. 
 
region in Figure 4.5). The two enantiomers of compound 1 were docked five 
MKP-1 conformation, resulting in 3,000 docking poses. Analysis of the resulting
poses to retrieve dominant patterns and identify the most favorable poses reveale
solvent-exposed side-chains of His229 and Phe299 in optimizing the interactions with the
Ile262 and the β-carbons of Ser263 and Asn298 were observed. Comparable i
observed with MKP-3. Cdc25B and VHR, on the other hand, la
 
Figure 4.5 CD structures and docking solutions for MKP-1 inhibitors. 
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 (A) Template structures used in modeling the MKP-1 catalytic domain. The inhibitor docking
Docking solutions for enantiomers of compound 1. Note the interactions with H229 and F299,
with A260, I261 and R264 on the HCX5R motif. Inhibitors are shown in a ball-and-stick represe
colored green. Approximatel
 site is encircled. (B) 
 in addition to those 
ntation with C atoms 
y 5% of docking poses in the same bound state/cluster are shown transparently. Figure 
is adopted from (Bakan et al., 2008). 
 
 
itors. However, 
members of the 
especially in the 
), while 
the His229 position appears to sustain substitutions to Trp, Asn or Glu, which may impart some 
 against MKP-3 
is substituted by 
 observations, in 
lighted the need 
for locating other binding sites on MKP-1 for designing selective inhibitors. We also note that 
ased on models generated using the active state structures of the MKP 
catalytic domains listed in Table 4.1. Further studies considering the inactive conformation of 
the active site loop, as well as the accessible conformations predicted by normal mode analysis, 
are expected to assist in generating more accurate and comprehensive predictions of MKP-
inhibitor interactions. 
 
These observations suggest some criteria for designing MKP inhib
achieving selectivity remains a challenge. Sequence comparison between the 
MKP family shows that MKP-1 shares a high sequence identity with others 
active site region (Table 4.1). Specifically, Phe299 is highly conserved (see Figure 4.2
selectivity. MKP-1 inhibitors are known to have comparable inhibitory potency
(see the IC50 values in Figure 4.3). We note that the MKP-1 His229 residue 
Trp264 in MKP-3. Docking to an ensemble of MKP-3 models resulted in similar
accordance with their comparable inhibitory activities. These observations high
these simulations were b
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4.3 A NOVEL MKP-3 INHIBITOR FROM ZEBRAFISH CHEMICAL SCREENS 
4.3.1 Zebrafish chemical screens identify a novel MKP-3 inhibitor 
ycoproteins that 
fulfill important functions in development, proliferation and cellular homeostasis (Thisse & 
ilar 
 MKP-3 achieves 
a small molecule 
dro-1H-inden-1-
one (BCI), using a transgenic zebrafish chemical screen (Molina et al., 2009) (see Figure 4.6). 
ents and in vivo chemical complementation assays were used to 
determine MKP-3 as the target of inhibitor BCI. BCI also showed comparable activity against 
MKP-1. IC50 values measured in vivo for MKP-3 and MKP-1 were 12.3 ± 4.0 µM and 11.5 ± 2.8 
µM.  
 
Fibroblast Growth Factors (FGFs) are members of a large family of secreted gl
Thisse, 2005). MKP-3, and other signaling proteins such as Sproutys (Spry1-4) and Sef (sim
expression to FGFs) proteins, function as feedback regulators of FGF signaling.
this role by limiting the activity of ERK-1 and 2. Our collaborators identified 
modulator of FGF signaling, (E)-2-benzylidene-3-(cyclohexylamino)-2,3-dihy
Zebrafish control experim
 
Figure 4.6 BCI structure (A) and zebrafish embryos before (B) and after (C) BCI treatment. 
Panel B shows a control experiment using transgenic zebrafish embryo. GFP is tagged to MKP-3 gene (Dusp6). 
Panel C shows that BCI hyperactivates FGF signalling, which is measured by the increase in GFP tagged MKP-3 
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amount. Note that this does not necessarily mean that BCI interacts with MKP-3. Identification of MKP-3 as the 
targ of BCI required additional experiments (Molina et al., 2009). Figure is adopted from (Molina et al., 2009). 
 mechanism, we 
BCI within the 
phosphatase domain. In vitro studies supported the model that BCI uniquely inhibits MKP-3 
rs and controlling 
tages. This study 
pounds targeting 
 signaling pathway that eludes traditional high-throughput in 
vitro screens. Here, we give the details of computational modeling and show results from in vivo 
 
A two-step process was adopted for predicting the optimal binding poses of BCI and assessing 
ed docking simulations were performed 
where the target protein (MKP-3) was assumed to be rigid either in the low-activity state or the 
high-activity state. These simulations permitted us to build two hypotheses, one of which was 
supported by more detailed flexible docking simulations. In the following, the method and 
results from the two successive steps are described in more details.  
 
et 
 
To identify a putative binding site for BCI and to elucidate its inhibition
performed docking simulations. We identified an allosteric binding site for 
activation by ERK. A temporal role for MKP-3 in restricting cardiac progenito
heart organ size was uncovered with BCI treatment at varying developmental s
highlights the power of in vivo zebrafish chemical screens to identify novel com
MKP-3, a component of the FGF
experiments conducted to test our models. 
4.3.2 Putative binding site and inhibition mechanism from modeling 
the potential mechanism of inhibition. First, unbias
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4.3.2.1 Identification of potential bindings sites using unbiased docking 
king simulations 
onformations of 
raphy (PDB ID: 
ORCHESTRAR (Tripos, Inc., St. Louis, MO). We used as templates the structures of MKP4 
ID: 1ZZW; 47% 
 identity) (Jeong 
nantiomer) were 
Genetic algorithm population size was set to 250. Each docking pose was selected based on the 
energetic evaluation of up to 5 x 106 alternative conformations.  
 
Crystal structures of MKP catalytic domains enabled us to perform unbiased doc
to identify potential BCI binding sites. BCI was docked onto two different c
MKP-3: the low-activity (or basal-activity) form determined by X-ray crystallog
1MKP) (Stewart et al., 1999) and the high-activity form obtained by homology modeling using 
(PDB ID: 2HXP; 80% sequence identity) (Almo et al., 2007), MKP5 (PDB 
sequence identity) (Jeong et al., 2006), and VH3 (PDB ID: 2G6Z; 44% sequence
et al., 2007) in the high-activity state. For BCI, 400 docking poses (200 per e
generated using AutoDock4 for each conformation (Morris et al., 1998; Huey et al., 2007). 
 
Figure 4.7 Results from unbiased docking simulations of BCI. 
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Results for low-activity (A) and high-activity (B) states are shown. Each BCI docking po
represent multiple docking solutions in a cluster. The clusters in the vicinity of the catalyti
Clusters are determined using agglomerative clustering. The averag
se colored distinctly 
c site are encircled. 
e heavy-atom RMSD (only BCI heavy atoms are 
used within a cluster is less than 2 Å. Figure is adopted from (Molina et al., 2009). 
The analysis of the resulting poses using an agglomerative clustering scheme revealed the 
clustering of a subset of binding poses in the vicinity of the active site in both conformations. In 
se upon catalytic 
 for this site is -
s crevice is not 
was predicted to serve as an alternative binding site for the inhibitor. Predicted binding free 
free energies are 
(Eldridge et al., 
potential sites for further focused docking simulations, rather than making a conclusive 
assessment of the binding pose and energetics. Therefore, not so much weight is usually put on 
Aut 7. They were not 
 in the first place, as BCI binding to those sites did not seem to possibly interfere with 
ERK binding or with the functional dynamics of the catalytic domain. 
 
Based on predicted sites shown in Figure 4.7 two potential inhibition mechanisms were 
hypothesized: 
) 
 
the low-activity state (Figure 4.7A), the binding site was a crevice known to clo
activation of the enzyme. The average AutoDock binding free energy for BCI
6.64 kcal/mol (equation 2.4.6). In the high-activity state (Figure 4.7B) thi
accessible. Instead, a relatively more hydrophobic patch in the neighborhood of the active site 
energy for this site is -6.22 kcal/mol. Please note that the predicted binding 
within the standard error of most scoring functions (larger than 2 kcal/mol) 
1997; Huey et al., 2007), and they can be easily offset by small rearrangements in the protein 
backbone and side-chains. Due to these limitations, this unbiased docking step was used to locate 
oDock predicted energies. Also, other potential sites are shown in Figure 4.
considered
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 ty of the general 
hanges that lead 
-3 catalytic activation. This restricts ERK2 dephosphorylation to a basal 
catalytic rate. 
 
2. BCI binds the ERK-activated MKP-3, and prevents ERK2 from optimally orienting 
 prevent MKP-3-ERK2 complex formation (at 
least ERK2 binding to MKP-3 binding domain) due to the large surface area of interaction 
hanisms  
Toward an assessment of the more likely inhibition mechanism among those hypothesized 
Incorporation of 
 
inactive state is known, the general acid loop configuration is stabilized by crystal contacts in 
this structure as shown in Figure 4.8. In the absence of these contacts, this loop may assume a 
different conformation. (ii) The activated state of MKP-3, on the other hand, is not known. A 
single homology model may not represent MKP-3 activated state faithfully. 
 
1. BCI binds the low-activity form of MKP-3 and restricts the mobili
acid loop so as to prevent ERK2 from inducing the conformational c
to MKP
itself, which leads to the inhibition of ERK2 dephosphorylation. 
 
In either case, BCI was not expected to
distributed over two domains of MKP-3 (Zhou et al., 2006). 
 
4.3.2.2 Flexible docking for a detailed assessment of potential inhibition mec
above, we further explored the binding properties of BCI by allowing the protein to undergo 
structural fluctuations in the neighborhood of the two above-defined states. 
backbone flexibility was important for two reasons: (i) although an X-ray structure of the
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 Figure 4.8 MKP-3 general acid loop (encircled region) makes crystal contac
Two units in the structure 1MKP resolved by (Stewart et al., 1999) are show
 
Conformations accessible near the basal-activity state were sampled by
(Atilgan et al., 2001) in combination with all-atom energy 
ts. 
n. 
 using the ANM 
minimization. Third, fourth, and fifth 
2 toward to the 
catalytic cavity (Figure 4.9) (see results at ANM web server www.ccbb.pitt.edu/anm/
ANM slow modes were found to induce a displacement in the catalytic Asp26
  (Eyal et 
l
al., 2006) using the PDB ID 1MKP) (see also Supplementary Movie 1 at 
http://www.nature.com/nchembio/journal/v5/n9/suppinfo/nchembio.190_S1.htm ). The general 
cavity within the 
first 10 ns of unbiased MD simulations, in line with ANM calculations. These modes were 
linearly combined using scaling factors obtained from Equation 2.3.1. The high-activity state 
model was used as the target conformation. NAMD software (Phillips et al., 2005) and the 
CHARMM force field (Brooks et al., 2009) were used for energy minimization. For each α-
acid loop was also observed to have a tendency to move towards the catalytic 
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carbon, harmonic restraints with a force constant of 40 kcal/mole/Å  were defined to drive the 
ently introduced 
 (10 along each 
intly optimizing 
state, multiple models generated 
with MODELLER (Sali & Blundell, 1993) were used as targets.  
 
2
motions along the selected ANM modes at steps of size < 0.2 Å, similar to rec
ANM-steered simulations (Isin et al., 2008). A total of twenty conformations
direction of the combined mode) were sampled along the selected modes by jo
backbone and side-chain conformations. As for the high-activity 
 
Figure 4.9 Combined ANM mode direction (A) and alternative MKP-3 conformations along this mode
 
 
During docking simulations, the completely solvent-exposed side-ch
 (B). 
ains have been 
allowed to sample rotameric states from the Penultimate Library (Lovell et al., 2000) of isomeric 
states. In the low activity state, Asp262, Trp264, and Asn335 were flexible. In the high-activity 
state, Trp264 and Phe334 were flexible, as the Asp262 and Asn335 were buried in this case. At 
least 1000 docking poses for the basal and activated state were generated using GOLD (Jones et 
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al., 1997) and cluster analysis was performed. Docking poses were scored using GoldScore 
(Jones et al., 1995) (see methods for details).  
ere examined to 
large cluster size) of BCI docking poses were located in the low-activity conformation. The most 
eraged over all 
see section 2.6.2 
rticular, the BCI 
al acid loop and 
helix α7, rather than interacting directly with the catalytic residues Asp262, Cys293, or Arg299. 
At this putative binding site, a close interaction of BCI with the backbone of the general acid 
loop and the side-chains of Trp264, Asn335 and Phe336 was predicted (Figure 4.10).  
 
 
The most populated (and therefore entropically favorable) clusters w
identify the likely binding modes. The most favorable clusters (high GoldScore average and 
populated cluster is shown in Figure 4.10. The corresponding GoldScore av
binding poses for this cluster was found to be 47.2 ± 2.1 (236 of 1000 poses) (
for details of this score), in favor of the hypothesized binding pose (i). In pa
molecule was predicted to preferentially fit within a crevice between the gener
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 Figure 4.10 BCI interactions predicted using focused and flexible docking
Figure is adopted from (Molina et al., 2009). 
 
Finally, as a further verification, docking simulations were performed
binding properties of BCI against VH3, MKP-1 and MKP-3. BCI was docked o
structure of VH3 (PDB ID: 2G6Z) and a model of MKP-1 based on MKP-3 st
much lower docking scores (27.9 
. 
 to compare the 
nto to the crystal 
ructure using the 
same procedure as described above for MKP-3. Docking to the VH3 crystal structure yielded 
± 1.4) due to lack of the crevice observed in MKP-3 (Figure 
4.11 ), explaining lack of activity against this constitutively active homolog. Docking of BCI to 
the MKP-1 model resulted in comparable interactions but lower GoldScores (37.4 ± 2.9) (Figure 
4.11A). This rationalizes BCI activity observed in zebrafish experiments and in vivo assays 
(Molina et al., 2009). 
 
B
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 Figure 4.11 BCI interactions with (A) MKP-1 and (B) VH3. 
Figure is adopted from (Molina et al., 2009). 
 
 small molecule 
phosphatase substrate, 3-O-methylfluorescein phosphate (OMFP), by MKP-3 in the presence or 
absence of ERK2. Docking simulations predicted that BCI and OMFP could simultaneously bind 
talytic residues 
sphatase activity 
toward OMFP. Indeed, at a concentration that inhibited ERK dephosphorylation in vitro (100 
µM, Figure 4.12B), BCI did not inhibit basal MKP-3 activity (Figure 4.12B). Addition of ERK2 
stimulated MKP-3 dephosphorylation of OMFP three-fold and this enhancement was 
significantly inhibited in the presence of BCI (Figure 4.13B). These data support the modeling 
4.3.3 Experimental testing of the hypothesis 
To test these modeling predictions, we measured the dephosphorylation of a
within the phosphatase active site with OMFP interfacing with the core ca
(Figure 4.12A). This suggests that BCI would not block basal MKP-3 pho
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predictions that BCI is a specific allosteric inhibitor of MKP-3 that prevents the catalytic 
stim induced by substrate binding.  
 
ulation of phosphatase activity 
 
Figure 4.12 BCI does not inhibit OMFP phosphorylation. 
(A) OMFP, an artificial small-molecule substrate of MKPs, and BCI docking poses do not overlap. Hence, BCI is 
not expected to inhibit dephosphorylation of OMFP by MKP-3. (B) Experiment showing that BCI is not effective in 
in vitro OMFP dephosphorylation experiments at concentration 20 times higher than that is effective in zebrafish 
experiments. BCI activity is compared to NSC95397 activity. NSC95397 is an in vitro active MKP inhibitor (Vogt 
et al., 2008). Figure is adapted from (Molina et al., 2009). 
 
 
Figure 4.13 BCI is an allosteric inhibitor of MKP-3. 
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(A) Low-activity state MKP-3 structure is compared to high-activity state VH3 structure. 
putative binding site, BCI is postulated to obstruct the flexibility of MKP-3 general acid loop so
induced activation. (B) Experiments showing that BCI inhibits ERK stimulated activation of M
ERK-2 stimulated OMFP dephosphorylation by MKP-3 three-folds (raise from □ to ■) and
When bound at the 
 to prevent its ERK 
KP-3. Addition of 
 this enhancement was 
signi cantly inhibited in the presence of BCI (decrease from ■ to ●). Figure is adapted from (Molina et al., 2009). 
 
culiar structural 
characteristics of this class of signaling enzymes have been the limiting factor of the overall 
 interactions and 
rboxamides and BCI. In fact in our view, 
the discovery of BCI and its unique MKP inhibition mechanism is the most important progress 
mad ps et al., 1998) 
and determination of the structure (Stewart et al., 1999) of MKP-3.  
h. Standard tools and 
approaches, such as using a single target conformation or evaluating docking poses solely based 
on scoring function, would have held back our progress. Considering alternate MKP 
conformations in docking and ensemble (clustering) analysis of docking poses enabled us 
locating putative binding sites and elucidating inhibition mechanisms of MKP inhibitors.  
 
fi
4.4 DISCUSSION 
MKPs are therapeutically important, but challenging targets. The pe
progress in the field. Our molecular models have provided first insights into the
selectivity of two classes of MKP inhibitors, pyrrole ca
e in the field since the elucidation of catalytic activation mechanism (Cam
 
In our work, we benefited from ‘ensemble analysis’ approac
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A limitation of our models is partly due to the small range of experimental IC50 values 
ole carboxamide, 
 notable pyrrole 
, 2007). Docking 
JPET/
that MKP inhibitors exhibit. In section 4.2, we showed results for only one pyrr
PSI2107. In our published work, we discussed experimental results for 9 more
carboxamides from the larger screening library of 172 compounds (Lazo et al.
poses for these compounds can be found at http://www.ccbb.pitt.edu/cadd/open/MKP/ . 
The IC  values of these compounds range from 8 to 19 µM. In addition to these, the compounds 
 the affinities of 
he standard error 
ompounds with 
nderstanding 
the selectivity of these compounds and identifying residues potentially important for binding. A 
3-dimensional structure activity relationship that can be predictive of activities of new 
compounds could not be developed. 
 
50
with lowest measured activity had IC50 values of 30 µM. Hence, the difference in
the best (PSI2107) and worst compounds in this library is much smaller than t
of most docking scoring functions (scoring functions cannot rank order c
maximum binding affinity difference less than 100 folds). This has limited us to u
 
Figure 4.14 Multiplicity of BCI binding modes. 
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Alternate BCI binding modes with comparable docking scores are shown. Gold score average for (A) is 47.2 ± 2.1 
(236 oses) and for (B) is 46.1 ± 2.9 (156 poses). 
s. Although our 
 multiple likely 
binding modes at the putative binding site. Two alternate configurations of BCI, for one of its 
e chirality 
 to improve its 
procedure. Once 
the more potent enantiomer of BCI and its most populated configuration is identified, it will 
f the ways to 
crystallographic, data on MKP-3 and BCI complex. An alternate way is an iterative design-
synthesis strategy, whereby new computational hypotheses can be evaluated by specifically 
prepared synthetic small molecules. This will be discussed in the last section of this work. 
 
 
 
 p
 
Another limitation arises from the weaknesses of typical scoring function
BCI interaction model is supported by novel in vitro experiments, we have
enantiomers, are shown in Figure 4.14. This multiplicity is further complicated by th
of BCI, which exists as two enantiomers. Not being able to single out the most populated BCI 
configuration, prevents us from suggesting modifications on BCI structure
potency. Hence, the design of compounds based on BCI is yet a trial and error 
enable the rapid development of more potent and possibly selective analogs. One o
achieve structure-based design of BCI analogs is of course to obtain structural, preferably X-ray 
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5.0  UNDERS MECHANISMS OF MEMBRANE 
PROTEINS 
t protein and its 
is the primary computational tool to model these interactions (Brooijmans & Kuntz, 2003) and 
istic/antagonistic 
s of docking to 
nt GPCRs in in 
cially available libraries and identified 11 compounds per target, with an 
average hit rate of 17% (Becker et al., 2004). In another study, Wang and coworkers targeted 
levels, with 60% 
The ligand-selective conformational heterogeneity of GPCRs has been recognized, 
however, as a limiting factor in in silico efforts (Kenakin, 2003; Kobilka, 2007). The binding site 
geometry of GPCRs differ, depending on the functionality and the potency of bound ligands 
(Ghanouni et al., 2001). Kinetic measurements and single molecule spectroscopy both reveal that 
TANDING FUNCTIONAL 
5.1 INTRODUCTION 
As we have discussed above, understanding the interactions between a targe
inhibitors is of crucial importance in drug discovery (Congreve et al., 2005). Molecular docking 
screen compound libraries of small-molecules with potential inhibitory/agon
activities (Shoichet et al., 2002). There are numerous successful application
membrane proteins. Predix Pharmaceuticals, for example, targeted five differe
silico screens of commer
dopamine (D3) receptors, and identified four compounds that bind at 100 nM 
hit rates (Varady et al., 2003).  
 
 117 
the 7 trans-membrane (TM) helix bundle samples distinguishable conformational states in the 
tates shift upon 
cking programs 
small number of 
mers. Overlooking backbone conformational flexibility 
hampers the success of in silico drug discovery. 
 algorithms and 
Abagyan, 2008; 
In particular, a ligand-steered homology modeling approach was developed, which uses existing 
 The idea therein 
ns of the target 
obed by flexible 
he utility of this 
one receptor 1 
where a 10-fold improvement over random high-throughput-screening was achieved and six 
interactions with 
AR (Reynolds et 
al., 2009). The models were reduced and further refined by flexible docking of selected agonists 
in the light of mutagenesis data to obtain models that outperformed rhodopsin-based models. In 
accord with these findings, Kobilka and coworkers reported that rhodopsin-based homology 
models of β2AR developed prior to β2AR structure resolution were more similar to rhodopsin 
absence or presence of ligand, and the populations of these conformational s
ligand binding (Peleg et al., 2001; Swaminath et al., 2004). State-of-art do
usually allow for only partial binding site flexibility limited to optimizing a 
side-chain rotations or short loop confor
 
Abagyan and coworkers made prominent contributions to developing
tools that take account of target protein conformational flexibility (Totrov & 
Bottegoni et al., 2009), which have been successfully applied to GPCRs (Cavasotto et al., 2003). 
ligands to shape and optimize the GPCR’s binding site (Cavasotto et al., 2008).
is to start with hundreds of crude homology models as probable conformatio
protein, then filter them based on their interaction energy with known ligands pr
docking and on their ability to detect known ligands in virtual screening tests. T
approach was demonstrated by its application to melanin-concentrating horm
novel antagonists were identified. In a similar recently published study, β2AR 
agonist/antagonist were examined upon generating multiple conformations of β2
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rather to β AR (Cherezov et al., 2007), stipulating the need to consider more distinctive target 
conformations. 
 as an important 
interactions. NMA with ENMs appears to be particularly suitable for generating backbone 
 of energetically 
to refine/broaden 
 for sampling of 
re. Our results 
show that ANM is able to capture robust collective modes of motions of not only soluble 
proteins, but also membrane proteins, despite the changes in the environment due to the lipid 
bilayer. Hence, we can say that functional motions correlate with intrinsic dynamics of the 
proteins which can be represented using simple physics-based models. 
 
G-protein coupled receptors constitute one of the largest protein superfamilies in the human 
genome with more than 800 members. Among the five families that form this superfamily, the 
rhodopsin family is the largest, with 701 members (Fredriksson et al., 2003). All GPCRs share a 
2
 
The generation of multiple conformations for the target protein emerges
component of computational tasks for modeling and simulating membrane protein-inhibitor 
rearrangements. It suffices to have but one structure to generate a distribution
favorable conformations in its neighborhood. Likewise, the method can be used 
an existing collection of conformations. Here, we illustrate the utility of ANM
alternate conformations of rhodopsin and nAChR and review the relevant literatu
5.2 RHODOPSIN 
5.2.1 G-protein couple receptors 
 119 
common architecture of seven TM α-helices (H1-H7) (Figure 5.1A). They transmit EC signals 
anges in the CP 
tivation, which, in turn, triggers a cascade of cellular 
responses (Kobilka, 2007; Oldham & Hamm, 2008).  
 
 done using the 
alczewski et al., 
2000). In addition to the bundle of seven TM helices, referred to as opsin, the structure contains 
main 
in contains three 
-H4 and H5-H6, 
ntains a β-sheet, 
which serves as a lid to the chromophore binding pocket, stabilized by a highly conserved 
ise to a local 
ment of the TM helical 
bundle to the CP domain, inducing an opening at the conserved D(E)RY motif (residues shown 
in sphere representation in Figure 5.1), which is recognized by the G-protein (Figure 5.1B). The 
active form, metarhodopsin II, is reached after a series of photointermediates. It binds the 
heterotrimeric G-protein, transducin, and interacts with several other signaling proteins.  
to the CP region via allosteric movements of TM helices. The resulting ch
surface facilitate G-protein binding and ac
5.2.2 Rhodopsin 
The vast majority of the structure-based computations for GPCRs have been
bovine rhodopsin structure, originally resolved by Palczewski and coworkers (P
an 11-cis-retinal (chromophore) deeply embedded in the core (Figure 5.1A). The EC do
consists of the N-terminus and three inter-helical loops EC1-EC3; the CP doma
inter-helical loops CL1-CL3 connecting respective pairs of helices H1-H2, H3
and a C-terminal helix H8 that runs parallel to the membrane. The EC domain co
disulfide bond between Cys110 and Cys187. The retinal, covalently bound Lys296 on H7, 
undergoes a cis/trans isomerization upon light activation. This gives r
conformational strain that propagates through the concerted rearrange
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 Figure 5.1 Rhodopsin (A) (chromophore in magenta) and G-protein bound ops
 
Recent years have witnessed a remarkable progress in the number of new
structures (Hanson & Stevens, 2009). Comparison of the structures of bovine
protein-interacting form (referred to as opsin*) (Scheerer et al., 2008) and rhod
in* (B). 
ly solved GPCR 
 opsin in its G-
opsin shows, for 
example, an outward tilt of 6 Å in TM6, and pairing of TM5 to TM6. Comparison of the ligand-
free tural difference, 
vated state in the 
 
The type and extent of conformational changes undergone upon activation of rhodopsin 
have been extensively examined by various experiments (Resek et al., 1993; Farrens et al., 1996; 
Altenbach et al., 1996; Hubbell et al., 2000; Altenbach et al., 2001a; Altenbach et al., 2001b; 
 opsin (Park et al., 2008) and opsin*, on the other hand, shows little struc
suggesting that the opsin conformational population is shifted towards the acti
absence of retinal and G-protein.  
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Hubbell et al., 2003; Kusnetzow et al., 2006; Bhattacharya et al., 2008; Altenbach et al., 2008) 
ader et al., 2004; 
 Grossfield et al., 
der et al., 2004; 
 
includes the chromophore binding pocket and a number of highly constrained conserved residues 
on the isomeric 
body movements 
ese cooperative 
ERY motif at 
the G-protein binding site. A model for the Meta II state has been proposed by analyzing the 
njunction with experimental data (Isin et al., 2006). The model was 
shown to correctly predict 93% of the experimentally observed effects in 119 rhodopsin mutants 
for which the decay rates and misfolding data have been reported, including a systematic 
analysis of Cys to Ser mutations.  
 
With the elucidation of a large number of structures, we are now in a position to examine more 
closely the correlation between the experimentally observed structural differences and 
theoretically predicted conformational changes. We performed a PCA of currently available 
rhodopsin and opsin structures, and compared the resulting PC modes to ANM modes. Our 
and computations (Rohrig et al., 2002; Saam et al., 2002; Crozier et al., 2003; R
Shacham et al., 2004; Huber et al., 2004; Lemaitre et al., 2005; Isin et al., 2006;
2007; Isin et al., 2008; Bhattacharya et al., 2008). GNM and ANM studies (Ra
Isin et al., 2006) show that the global mode is controlled by a broad hinge-bending region that
in the close neighborhood such that the structural changes locally induced up
transition of the cis-retinal are efficiently propagated through cooperative rigid-
of the TM helices, towards both the CP and EC regions. An effect of th
movements is opening the CP ends of the TM helices 3, 4 and 6, thus exposing the 
lowest ANM modes in co
 
5.2.3 PCA of rhodopsin structure ensemble 
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dataset includes 16 structures, comprised of 14 rhodopsin and two opsin X-ray structures. Out of 
tures, excluding 
t the C-terminus. 
n in Figure 5.2. 
e 
dataset. The PCA clearly separates the structures into two clusters along the first principal axis. 
 in Figure 1.2. 
)state, and 
ode 1 therefore 
rmations of 
which are displayed in Figure 5.3A. The 2nd principal mode, on the other hand, further 
disperses the structures within the first cluster. This mode essentially refers to the changes in 
loop conformations and termini orientations. These can be viewed as the microstates in the 
inactive substate.  
 
N = 348 residues, 312 are commonly resolved in the dataset of examined struc
the segments 230-240 on CL3, 311-313 between H7 and H8, and 327- 348 a
The distribution of the structures along the first two principal modes is show
These two modes contribute about 62% and 12% respectively, to the structural variability in th
These two clusters may be viewed, in a sense, as the two substates illustrated
Notably, the first cluster includes all the 14 rhodopsin structures in the inactive (sub
the second, two opsin conformations in the putative active (sub)state. M
unambiguously distinguishes between these two substates, representative confo
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 Figure 5.2 PCA of rhodopsin structural ensemble. 
Distribution of 16 X-ray structures in the subspace spanned by the PCA mode directions 1 and 2. These respective 
modes account for 62 % and 12% of the structural variability in the dataset. The principal axis 1 differentiates the 
inactive and (putative) activated structures which are clustered in two distinctive groups, and the PCA axis 2 further 
dopsins.  
 
5.2.4 Correspondence between ANM modes and PCA modes 
osely reproduced 
 principal axes 1 
rge as that along 
p2. Thirdly, and most importantly, the principal modes may be directly compared with those 
predicted by NMA. The PCA modes are exclusively based on experimental data for an ensemble 
of structures, while ANM modes are predicted by the theory for a single structure. Comparison 
of the two sets can help benchmark the computational predictions provided that the experimental 
differentiates between the structures in the cluster of inactive rho
Panel B in Figure 5.3 illustrates how the rhodopsin conformation (green) is cl
upon reconfiguring the opsin structure along p1. Comparison of the range of the
and 2 in Figure 5.2 shows that the size of motions along p1 is at least twice as la
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dataset represents a more or less complete ensemble (see for example the study performed by 
oth sets involve 
plete. Yet, ANM 
 cluster showed 
1 odes intrinsically 
accessible to opsin; and a cumulative overlap of 0.74 with the first 20 ANM modes accessible to 
ide a reasonable 
d by moving the 
Figure 5.3C. These results again confirm 
the view that the relative movements of the TM helices 5 and 6 observed upon light activation 
are intrinsic properties encoded in the rhodopsin architecture.  
 
Jernigan laboratory for HIV-1 protease), or consolidate the results, given that b
approximations. In the present case, the set of PDB structures is far from com
calculations performed for the two representative structures (labeled) from each
that p  exhibits a cumulative overlap of 0.79 with the first 20 ANM m
rhodopsin. Thus 2% of 930 ANM modes from the low frequency regime prov
description of the change observed experimentally. The reconfiguration predicte
opsin structure along these ANM modes is shown in 
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 Figure 5.3 Opsin structures deformed along PC and ANM modes. 
(A) Superimposition of experimentally determined rhodopsin and opsin structures. (B) R
generated by defo
hodopsin structure 
rming the opsin structure along the first principal mode, p1. (C) Rhodopsin conformation predicted 
by deforming the opsin structure along the 20 lowest frequency ANM modes. Structural models in B and C 
contained Cα atoms, only; the remaining backbone atoms were reconstructed with BioPolymer module of Sybyl 8.3 
(Tripos). ANM calculations were performed using the relatively short cutoff distance of Rc = 8 Å, so as to release 
interhelical constraints. 
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5.3 NICOTINIC ACETYLCHOLINE RECEPTOR 
 
5.3.1 Ligand-gated ion channels 
 
ligand-gated ion 
nsmitter causes 
 membrane. The 
opening and closing of LGICs rapidly convert chemical signals into an electrical output, 
regulating the flow of information. Mutations in LGICs lead to a number of ‘channelopathies’ 
such as congenital myasthenic syndromes, epileptic disorders and hereditary hyperekplexia 
-molecule drugs target LGICs (Figure 1.5). 
 
transmitter-gated 
eceptors, which include the serotonin 5-HT3, GABA A and 
GABA C, and glycine receptors. Members of this superfamily contain a signature loop of 13 
residues closed by a disulfide bridge, called Cys-loop, at the interface between the EC and TM 
domains of their respective monomers (Sine & Engel, 2006). The nAChR activity is triggered by 
binding of acetylcholine (ACh), or nicotine.  
Communication between nerve cells takes place at junctions called synapses. The presynaptic
cells release, upon activation, neurotransmitters into the synapse, which bind to 
channels (LGICs) on the surface of the post-synaptic cells. Binding of neurotra
the channels to open, allowing the ions to flow across the postsynaptic-cell
(Czajkowski, 2005). Approximately 8.3% of small
5.3.2 Nicotinic acetylcholine receptor (nAChR) structure 
Nicotinic acetylcholine receptor is a member of a superfamily of pentameric 
ion channels, also called Cys-loop r
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 o-EM of tubular 
l., 2003; Unwin, 
α-subunits) have 
R), hence the pseudo-symmetric organization of the quaternary structure. The receptor is 
volved in binding 
inal domain of 
d in a curled β-
d by the soluble 
ACh binding protein (AChBP) (Brejc et al., 2001). There are two ACh binding sites at the 
TM helices. The 
he middle of the 
and tangentially 
around, the central five-fold axis (Miyazawa et al., 2003). Comparison of the ligand-free nAChR 
and ligand-bound AChBP structures suggests that ACh binding induces a local structural 
rearrangement (closure of two loops around ACh) to convert the α-subunits to their open 
(relaxed, R) state, which cooperatively triggers a transient opening of the channel pore at a 
distance of about 40 Å, thus allowing cations, particularly Na+ and K+, to pass through.  
 
The structure of nAChR in the closed state has been determined by cry
crystals grown from the electric organ of Torpedo marmorata (Miyazawa et a
2005). The structure consists of five subunits (α, β, δ, α, and γ), two of which (
a slightly distorted (closed or tense, T) conformation compared to the other three (open, relaxed, 
organized into three domains (Figure 5.4A): a large N-terminal EC domain in
the neurotransmitter, a TM pore domain, and a smaller CP domain. The N-term
each subunit is composed of an N-terminal α-helix and two β-sheets arrange
sandwich connected by the Cys-loop (Figure 5.4A). The same fold is exhibite
interfaces between the α-δ and α-γ subunits’ EC domains. The TM domains of individual 
subunits are composed of four helices, M1-M4, overall forming a cluster of 20 
pore lining helix, M2, is tilted radially inwards towards the central axis up to t
membrane. The outer helices (M1, M3 and M4) tilt both radially toward, 
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5.3.3 Models of nAChR channel gating 
ChR (Changeux 
ecka et al., 2007; 
e of nAChR and 
for the EC-TM domains of the homopentameric α  nAChR models based on the nAChR and 
 that the lowest 
the EC and CP 
s for the nAChR 
 are displayed in 
Figure 5.4A. Like all vibrational modes, this global mode gives rise to two sets of conformers, 
 
e TM channel of 
ed by clockwise 
Figure 5.4B, the 
five M2 helices lining the pore are displaced slightly away from the center during this particular 
996)) shows that a relatively small (up to ~ 3Å) increase in diameter is induced in 
the constriction zone, the original value of which is 5.7 Å in the known structure. The diameter 
of the first hydration shell of a monovalent cation is typically around 8 Å. This small opening of 
the pore induced by the global mode is thus expected to enable the passage of hydrated cations 
(Taly et al., 2005).  
 
Several models have been proposed for elucidating the gating mechanism of nA
& Edelstein, 1998; Hung et al., 2005; Taly et al., 2005; Cheng et al., 2006; Szar
Liu et al., 2008). NMAs performed by different groups for the complete structur
7
AChBP structures (Taly et al., 2005; Cheng et al., 2006) invariably showed
frequency mode is a concerted quaternary twist with counter-rotations of 
domains around the five-fold symmetry axis. We performed ANM calculation
structure with PDB ID 2BG9 (Unwin, 2005). The softest ANM modes directions
corresponding to positive and negative movements along the mode axis, manifested as opposite
torsions in this case. Of these two sets, one is found to induce an opening in th
nAChR: the counterclockwise torsional rotation of the TM domain accompani
rotation of the EC domain when viewed from the CP region. As can be seen in 
quaternary twisting. The calculation of the pore size profile along the TM channel (using HOLE 
(Smart et al., 1
 129 
 Figure 5.4 Ligand-gated ion channel nAChR structure and dynamics. 
(A) Structure of the EC and TM domains of nAChR (PDB ID: 2BG9). The secondary stru
blue) of the TM domain; and the remaining four monomers are shown in gray. The lowes
cture of one of the 
monomers (α) is colored to display the β-sandwich fold (red) of the EC domain, and the four TM helices (M1-M4; 
t frequency ANM mode 
indu es a quaternary symmetric twist as indicated by the arrows shown for monomer α. (B) CP end of TM domain 
(bot  circle indicates the 
een circles represent 
har et al., 2009). 
An increase in the pore radius by ~1.5 Å has indeed been suggested by MD and 
Brownian dynamics simulations to be sufficient to raise the computed conductance to ~ 22 pS, - 
a value comparable to the experimental measurements for the open channel (Corry, 2006). The 
above results from NMAs (including those obtained with ENMs) support the view that small but 
c
tom) and close up view of one of the monomers (monomer α, colored) (top). Red dashed
channel pore. Arrows indicate the collective movements of M2 helices along ANM mode 1. Gr
the CP end of the M2 helices after deformation along ANM mode 1. Figure is adopted from (Ba
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concerted rearrangements of the M2 helices lining the pore readily allow for an expansion of this 
Concerted rigid-
 of the original 
e single-channel 
ent of the helices 
M1, M2 and M3 between the open and closed forms of the channel (Cymes et al., 2005; Cymes 
ansfers (or pKa 
se helices. These 
arrangements, if 
mode predicted by the NMA does not necessarily implicate any significant change in the 
all rotations of 
ains, which may 
ons. The changes induced by the NMA-predicted quaternary 
twisting mode, in the exposure of M2 residues’ side chains to the central pore, were indeed 
pointed out by Changeux and coworkers to be compatible with the data from Grosman and 
served in other 
multimeric ion channels (Bahar et al., 2009). The collective modes of the M2 bundle (pore-lining 
helices) predicted by NMA are also observed in PCA of MD simulation trajectories (Hung et al., 
2005). Conventional MD simulations of 30ns for nAChR embedded in explicit lipid bilayer also 
indicate (Liu et al., 2008) the concerted rotations of M1 and M2 helices accompanying the 
size in the pore, thus providing an efficient gating mechanism (Unwin, 1995). 
body motions of M2 helices were inferred by Unwin from early comparisons
structures at various resolutions. Grosman and coworkers made extensiv
electrophysiological measurements to analyze the change in the microenvironm
& Grosman, 2008). Mainly, they examined the position-dependent proton tr
shifts) for ionizable residues that have been engineered in the inner faces of the
experiments led them to conclude that nAChR pore dilation involved subtle re
any, of these three helices (Cymes et al., 2005; Cymes & Grosman, 2008). Notably, the twisting 
orientation of the M2 helix side chains with respect to the channel lumen, but sm
about ~15⁰ that presumably induce minimal changes in the exposure of side ch
explain the experimental observati
coworkers’ experiments (Taly et al., 2005).  
 
The global twisting-to-open motion of nAChR resembles those ob
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shrinking of the ACh binding pocket, and the open-close transition of the structure can be driven 
 accord between 
tories conducted 
 membrane proteins’ 
intrinsic features in defining the movements that facilitate essential functions such as gating. 
ligand-gated ion 
channels shed further light into pore opening/closing mechanisms. These are the closed state 
IC) (Bocquet et 
 bundle, but bear 
hR. In particular 
for a missing α-helix. The most striking difference betw  the ELIC and nAChR structures is at 
nd Leu239 side-
 CP half is wide 
open state, being 
crystallized in the presence of an activating ligand proton. Figure 5.5 compares the ELIC and 
GLIC structures after their optimal superimposition. In addition to a symmetric tilt of the pore 
forming helices, the most visible difference is a quaternary twist similar to that observed in 
nAChR. Bocquet et al. (Bocquet et al., 2009) reported that the lowest ENM mode, a quaternary 
by introducing a torsional rotation around the pore axis in steered MD. The
NMA results for the nAChR in the absence of lipid environment, and MD trajec
in explicit water and lipid bilayer, corroborate the dominant role of the
 
5.3.4 Recent structures confirm quaternary twist-to-open mode 
The recently resolved X-ray structures of two bacterial homopentameric 
structure of Erwinia chrysanthemi ligand-gated ion channel (ELIC) (Hilf & Dutzler, 2008) and 
two open-state structures of Gloebacter violaceus ligand-gated ion channel (GL
al., 2009; Hilf & Dutzler, 2009). These structures do not include the CP helical
EC and TM domains comparable in size and fold to their counterparts in nAC
their EC domain superimposes closely with AChBP and with the EC domain of nAChR, except 
een
their pore domain: the EC half of the ELIC pore is occluded with Phe246 a
chains that narrow down the pore diameter to less than 1Å, while the remaining
open (diameter of 6 Å). The two GLIC structures, on the other hand, are in the 
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twist of the two domains, explains 29% of the structural difference between the cores of the 
t with a model of pore opening involving a 
quaternary twist and tertiary deformation (Bocquet et al., 2009).  
 
structures. Overall these structural data are consisten
 
Figure 5.5 Comparison of open and closed bacterial ligand-gated ion channels (LGICs). 
Comparison of bacterial homopentameric LGICs ELIC (2VL0) and GLIC (3EAM) shows the contribution of this 
quaternary twist mode to the conformational changes involved in activation. One subunit (closest to the viewer) is 
omitted to display the channel pore. Figure is adopted from (Bahar et al., 2009). 
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6.0  CONCLUSION AND FUTURE WORK 
ALL-MOLECULE BINDING 
es, HIV 
reverse transcriptase (RT), p38 MAP kinase, and cyclin-dependent kinase (Bakan & Bahar, 
es upon 
 elastic network 
we consider the 
edom of the system (> 3,000 for RT, and > 1,000 for 
kinases) are much larger than the number of structures in the datasets. Hence, the PCA results 
mational 
We could say that we analyzed the therapeutically relevant part of the conformational 
space that is accessible to these targets. Biologically relevant structural changes (e.g., those 
accompanying binding of protein substrates, such as cyclin-bound Cdk2) were not included in 
our datasets. The inclusion of such structures could show a broader picture. Hence, it is likely 
6.1 PROTEIN RECOGNITION DYNAMICS AND SM
6.1.1 Why aren’t some ANM modes observed in experimental datasets? 
We presented the most comprehensive structural analyses of three drug target enzym
2009). Our results show that the conformational changes sampled by these enzym
binding a broad range of ligands closely correspond to those predicted by
models. Despite the large size of these datasets, we should note that even when 
proteins at residue level, the degrees of fre
that we showed are not expected to provide a complete picture of the confor
heterogeneity that these proteins display in solution.  
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that some dominant solution modes are not observed in these X-ray datasets, due to their limited 
p ranking ANM modes, 
that didn’t find any counterpart among the PCA modes retrieved from experimental data. 
 
for these proteins 
are quite similar (compare Figure 3.7 and Figure 3.9). It is notable that in the p38 ensemble, the 
M mode 2 was 
pling of normal 
 it related to the 
by expanding the dataset and carefully analyzing the sequence differences at hinge sites critical 
our analyses e.g. 
arison of cAMP 
itted around 60 
A of this dataset 
showed that ANM1 is preferentially sampled by Cyclin A2 bound Cdk2. Comparing sequence 
ctures (there 
ing approach to 
understand why slow ANM modes are selectively sampled by this family of proteins. The 
sequence specificity was indeed not included in our computational models. As described above, 
ANM considers uniform masses for all residue types and uniform potentials for all pairwise 
interactions. Understanding this selective behavior may enable us to make educated choices 
size and scope. It is also possible that missing modes are one of the to
p38 and Cdk2 share the same fold, so the slowest three ANM modes 
ANM modes 1 and 3 were observed; whereas in the Cdk2-ensemble the AN
distinguished. The question that arises is: What may lead to such selective sam
modes? Is it related to the differences in the sequence of these proteins, or is
bound set of small molecules? It is one of our short term goals to find an answer to this question 
for slow motions. As mentioned above, we omitted certain protein kinases in 
cAMP dependent kinase which has over 80 structures in the PDB. A quick comp
PCA modes with ANM modes showed ANM2 corresponds to PC1. We also om
CyclinA2 bound Cdk2 structures, most of which also being inhibitor bound. PC
features of cAMP, Cdk2, and p38, and maybe other kinases with more than 20 stru
are over 15 different kinases with more than 20 structures), looks as a promis
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among slow ANM modes when generating alternative conformations rather than using slowest 
10-20 ANM modes blindly.  
ated fluctuations 
ely to exist in 
solution as the anti-correlated fluctuations of fingers and thumb domain (ANM2 ~ PC1) (see 
a mode closely 
binding does not 
lution dynamics 
Since we are only interested in the globular arrangement of RT subdomains, small angle x-ray 
solution solution 
hape information 
od is particularly 
in proteins when such changes involve hinge 
motions (Forster et al., 2008). It is also a very simple task to generate distance distributions from 
t to be a fruitful endeavor to seek for 
SAXS data on HIV-1 RT and compare them to our predictions. 
6.1.2 Potential improvements to ANM-guided conformer generation 
In MKP-3 studies, we utilized slow ANM modes to generate alternative MKP-3 conformations 
to be used in docking simulations. A combined ANM mode was introduced into an all-atom 
 
In the HIV-1 RT case, the ANM calculations showed that the anti-correl
of the fingers subdomain with respect to the RNase H domain (ANM1) is as lik
Figure 3.5). Yet, we do not find among the extracted crystal structures, 
corresponding to ANM1. This is presumably because NNRTI or DNA/RNA 
particularly stabilize a distinct configuration along this mode. The study of the so
of RT using NMR is beyond the limitations of this technique due the large size of the protein. 
scattering (SAXS) experiments seem useful. SAXS experiments provide low-re
data about the shapes of proteins (Koch et al., 2003; Putnam et al., 2007). The s
is in the form of a histogram of all pairwise distances in the protein. The meth
useful to identify structural changes of multi-doma
protein structures deformed along ANM modes. We expect i
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energy minimization scheme in terms of α-carbon harmonic restraints. A few recent studies 
. Cavasotto and 
e structure and 
ng deformation 
into energy minimization to generate conformations prior to docking (Floquet et al., 2006). May 
and Zacharias, on the other hand, relaxed the protein along the slowest 10 normal modes in their 
imp  
minimization. The normal mode restraints are typically introduced as weak forces compared to 
Equation 2.4.4). 
 Equation 2.5.2, 
 der Waals 
the FF potential 
which may render NM restraints ineffective. In response to this strong interaction, the atoms may 
blem when we 
tion for MKP-3 
from its low-activity state to its high-activity state. These transitions are available in the MPEG 
video accessible at the publication web site of our article ( 
http://www.nature.com/nchembio/journal/v5/n9/suppinfo/nchembio.190_S1.html
applied methods based on the same basic ideas to improve docking results
Abagyan used all-atom normal modes to deform a cAMP-dependent kinas
performed energy minimization to restore the covalent geometry followi
(Cavasotto et al., 2005). Floquet and Perahia introduced a single normal mode based restraint 
lementation of a coarse-grained docking protocol (May & Zacharias, 2008). 
 
All of these distinct procedures and ours are prone to the limitations of downhill energy 
the covalent potentials and to the repulsive component of the LJ potential (
During the energy minimization of a protein subject to a potential similar to
interatomic contacts that are closer than certain thresholds (defined by atomic van
radii) may result in strong repulsions, and therefore a very steep increase in 
exhibit umphysical responses, i.e. the molecule starts to diverge in an improbable direction, or 
the side-chains can assume unrealistic rotameric configurations. We faced this pro
used ANM-guided energy minimization to model a plausible structural transi
). The first 
movie (Supplementary Movie 1) shows the fluctuations of MKP-3 along the combined ANM 
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mode. Snapshots for this movie were generated in around 40 iterative minimization steps. The 
KP-3 from low-
 needed to reach 
 and decelerates 
of Arg299. In its inactive state configuration, Arg299 side-chain clashed with the closing loop 
atoms and delayed the transition. In the high-activity state MKPs, Arg299 assumed a different 
rota r transition.  
lecular dynamics 
simulation, whereby side-chains preventing the deformation or ANM-driven transition may jump 
 mode. This is in 
. Another similar 
(Miloshevsky & 
n a Monte Carlo 
simulation. The drawback of such Monte Carlo simulations is the duration of computations to 
reach distinct protein states. In molecular docking studies, one typically prefers to prepare the 
pro d more time in 
days, to sample 
protein conformations is not desirable feasible approach in most applications. 
 
As a practical alternative, we may pursue NMA-guided energy minimization of the 
structure after temporary removal of all side-chains. Residues other than glycine and proline are 
second movie (Supplementary Movie 2) shows the complete transition of M
activity to high-activity state. Over two hundred energy minimization steps were
the high-activity. As seen in the movie, the transition is rapid in the beginning
towards the end; and the Arg299 side-chain is distorted.  The primary obstacle was the side-chain 
meric state (compare two panels of Figure 4.11) which could enable an easie
 
Such limitations can be overcome by using ANM restraints in a mo
to alternative rotameric states that would enable the movement along the ANM
fact what Isin and Bahar developed in their study of rhodopsin (Isin et al., 2008)
method, Normal Mode Following, was developed by Miloshevsky and Jordan 
Jordan, 2006), in which the perturbations along normal modes are incorporated i
tein structure or the structural ensemble in less than an hour, and spen
performing the docking simulation. Spending a longer time, of the order of 
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then mutated in silico to alanine, so as to facilitate smooth backbone transitions. After an 
odeled back into 
WRL (Krivov et 
 removing side-
modes, in which most of the protein structure is preserved at its initial configuration. In MKP-3 
 site residues to 
-activity to the high-activity state. An 
automated procedure using Python programming and MMTK module of the PDB, as described 
above, may provide a powerful tool for flexible docking simulations. 
 
6.2 MKP INHIBITORS 
6.2.1 An iterative approach for designing more potent BCI analogs 
itory mechanism 
st efficient and 
50)] / Nheavy-atoms 
(Hopkins et al., 2004); BCI (Figure 4.6A) is almost twice as efficient as PSI2106 (Figure 4.3). 
As we discussed in section 4.4, our model is yet not appropriate for assisting in structure-based 
analog design, due to the multiplicity of the likely solutions found at the putative binding site. 
This type of ligand design is usually based on a single binding mode of the ligand, often coming 
ensemble of backbone conformations is prepared, side-chains can easily be m
the newly generated structures using side-chain placement programs, such as SC
al., 2009). In certain cases, one may also achieve smooth transitions by only
chains that make steric clashes. This may be especially convenient when using global/slow 
case, for example, the conversion of the general acid loop and other binding
alanine would enable an easy transition from the low
We have developed models to aid in understanding the selectivity and the inhib
of MKP inhibitors. Among those inhibitors that we studied, BCI is the mo
deserves further attention (ligand efficiency is defined as Δg = [-RT log(IC
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from an X-ray co-crystal structure. In the absence of such a structure, our short-term goal is to 
identify the BCI binding mode that contributes most to the affinity of this compound. 
is strategy. Our 
activity of these analogs has been assessed by Dr. Tsang Laboratory. These analogs bear 
 the cyclohexylamino moiety. Our plan is to overlay these 
analogs onto the BCI docking poses and to establish the relationship between the activity of the 
com
As a supporting method, we also plan to adopt a more accurate method for binding free 
discussed above, 
ms (section 2.6). 
ng methods that 
 a more rigorous 
way are now becoming more conveniently available. One such method is the PB/SA scoring. 
way to simulate 
art, on the other 
nterface between 
the protein and the ligand. This method is now implemented in DOCK 6 (Lang et al., 2009) and 
uses a fast electrostatics toolkit ZAP (Grant et al., 2001). It was also shown recently that, using 
ZAP libraries, the PB/SA scoring can be utilized in high-throughput calculations (Brown & 
Muchmore, 2006). We hypothesize that incorporating this more rigorous technique in an iterative 
 
Toward this aim, we would like to pursue an iterative design-synthes
collaborators in Dr. Day Laboratory have synthesized over 15 analogs of BCI. The inhibitory 
peripheral additions or substitutions in
pounds and their interactions with MKP-3.  
 
energy evaluation, so as to score the interactions of BCI and its analogs. As 
typical docking scoring functions are simply additions of pairwise interaction ter
These terms represent the protein-ligand interactions in vacuo. Superior scori
also account for the contribution of desolvation and electrostatic interactions in
The Poisson-Boltzmann (PB) part of this method (section 2.7.1) is an effective 
the effects of water molecules in biological systems. The surface area (SA) p
hand, accounts for desolvation of water from the hydrophobic surface at the i
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synthesis-design procedure will favorably aid in developing more potent BCI analogs for MKP 
inhibition. 
 
6.2.2 Characterization of the putative BCI binding site 
t discovery of 
olina et al., 
o aim at fully 
at makes up the 
putative site is flexible and has an intrinsic ability to close upon the catalytic cavity. We were 
 
ave the crystal 
present the most 
 such contacts. Our plan is to further investigate the 
structure and dynamics of this loop using MD simulations. The establishment of the most 
 may help us setup virtual screening 
simulations for the identification of new compounds. 
6.2.3 Estimating the druggability of the putative BCI binding site 
BCI is a ~10 µM inhibitor of MKP3. Can we improve its potency? Certainly, but what is the 
maximal affinity achievable at the putative binding site? We would also like to answer this type 
The shallow catalytic sites of MKPs make them a challenging target. The recen
BCI and the putative BCI binding site opened new directions in targeting MKPs (M
2009). This putative binding site also deserves more attention. We als
characterizing this site. ANM calculations showed that the general acid loop th
also able to generate alternative loop configurations (Figure 4.9). Yet, what we do not know at
this time are the weights of these alternative configurations. Although we h
structure, this loop is affected by crystal contacts (Figure 4.8) and may not re
populated configuration in the absence of
populated (or lowest energy) configuration of this loop
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of questions.  Recently, an MD simulation method for calculating druggability indices and 
d, the protein is 
c compound and 
stribution on the 
-based approach. 
The method may be advantageously employed toward the identification of novel binding pockets 
 this method to 
 binding site. 
ill seek other potential pockets that may remotely affect the flexibility of the 
general acid loop. If any, other novel pockets will also be tested by testing compounds identified 
 
After characterizing the BCI binding site, we plan to perform virtual high-throughput screening 
echanism as the 
 Pharmacophore 
acophore 
 task (Carlson et 
al., 2000).  A dynamic model is generated using multiple target conformations from MD 
simulations. Pharmacophoric features and constraints are based on the conserved interactions 
between the probe molecules and the ensemble of conformations. In our case, we can use 
conserved solvent interactions from water-isopropanol mixture simulations of MKP-3. We will 
identifying binding sites has been introduced (Seco et al., 2009). In this metho
simulated in a mixture of water and isopropanol. Isopropanol is a small organi
diffuses fast in MD simulations. Hereby, it serves as a drug-like probe. Its di
protein surface and cavities are converted into achievable affinities by a grid
in addition to assessing the druggability of known pockets. We plan to apply
MKPs in an effort to estimate the maximal achievable affinity of the putative
Further, we w
in virtual screens. 
6.2.4 Virtual screening for new chemotypes  
(vHTS) simulations for new chemotypes that work through the same allosteric m
BCI. We plan to incorporate the flexibility of the binding site in our screening.
based virtual screening methods are in general faster than docking. The dynamic pharm
model described by Carlson and McCammon seems particularly suitable for this
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use the Sybyl module Unity for 3D flexible pharmacophore based screening. We will also 
of commercially 
y holds over 8 
 used to select 
 
be energy optimized and scored using PB/SA scoring function. The final set of hits from vHTS 
will be tested using zebrafish embryos by our collaborators in Dr. Tsang lab. 
consider the ZINC database (Irwin & Shoichet, 2005) (http://zinc.docking.org/) 
available compounds for a more extensive screening. This database currentl
million drug-like compounds. The dynamic pharmacophore model will be
compounds that satisfy the desired features. The compounds derived from the initial search will
 143 
APPENDIX A 
LIST OF PDB STRUCTURES USED IN ENSEMBLE ANALYSIS 
 A. IDs of RT structures
 
M Q 1C0T  C DL 1DTQ 1DTT 1EET 
Table 1 PDB . 
1BQ  1B N 1C0U 1C1B 1C1  1 O 
1EP4 FK 1F V NI HN 1H 1HQE 1HQU 1 9 KO 1FKP 1HM 1H  1 V PZ 
1HYS K 1I   K JL 1JLB 1JLC  1I V KW 1IKX 1IKY 1J5O 1J H 1 A 
1JLE L 1JLG  0 1LWF 1J F 1JLQ 1KLM 1LW  1LW2 1LWC 1LWE 
1N5Y 6 1Q  1 T 1RT4 1RT5 1N Q E1 1R0A 1REV 1RT  1R 2 1RT3 
1RT6 T 1R  J 1T S 1S1V 1S1W 1R 7 TD 1RTH 1RTI 1RT 1S  1 1U 
1S1X 6  1S Q 1SUQ 1SV5 1T03 1T051S P 6 1S9E 1S9G  1TKT 
1TKX 1TKZ 1TL1 1TL3 1TV6 1TVR 1UWB 1VRT 1VRU 2B5J 
2B6A 2BAN 2BE2 2HMI 2HND 2HNY 2HNZ 2I5J 2IAJ 2IC3 
2OPP 2OPQ 2OPR 2OPS 2RF2 2RKI 2VG5 2VG6 2VG7 2ZD1 
2ZE2 3BGR 3C6T 3C6U 3DI6 3DLE 3DLG 3DM2 3DMJ 3DOK 
3DOL 3HVT         
Residues 4-63, 73-135, 142-443, 455-537, 1007-1064, 1068-1087, 1096-1212, 1233-1355, 1362-1427 
were included in the analysis, corresponding to 89.4% of HIV-RT sequence. These structures were 
resolved at 3.5 Å resolution or higher. The reference structure is the unliganded form of RT determined by 
Esnouf et al. (Esnouf et al., 1995) (PDB id: 1RTJ). PDB IDs are colored according to scheme in Figure 
3.1. 
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Table A.2 PDB IDs of p38 structures. 
A.  ID dk tur
 
. 
U L   N KV 1LEW 1LEZ 1A9 1B 6 1BL7 1BMK 1DI9 1IA  1 1 1KV2 
1M7Q U O  3 R 1W7H 1W82  1O K 1 UY 1OVE 1OZ1 1P38 1R 9 1 3C 
1W83 1W   T B 1WFC 1YQJ 1W84 BN 1WBO 1WBS 1WB  1W V 1WBW 
1YW2 W 1ZYJ  J A 2BAL 2BAQ 2EWA  1Y R 1ZZ2 1ZZL 2BA  2B K 
2FSL FS 2F  L GH 2GTN 2I0H 2 M SO 2FST 2GFS 2GH  2 M 2GTM 
2NPQ K 2O 5A  2PTJ 2PT  2PUU  2O R ZA 2P 2PKJ O 2PV5 2PV8 
2QD9 2RG5 2RG6 2ZAZ 2ZB0 2ZB1 3BV2 3BV3 3BX5 3C5U 
3CG2 3CTQ 3D7Z 3D83       
Residues 5-31, 36-114, 122-169, 185-351 w
 
ere included in the analysis, corresponding to 89.2% of p38 
MAP kinase sequence. These structures were resolved at 2.8 Å resolution or higher. The reference 
structure is the unliganded form of p38 determined by Wang et al. (Wang et al., 1997) (PDB id: 1P38). 
PDB IDs are colored according to scheme in Figure 3.1. 
 
Table 3 PDB s of C 2 struc es. 
1AQ1 3 1B  2 1 1FVT 1G5S 1B 8 39 1CKP 1DI8 1DM  1E V 1E1X 
1GIH GI 1GIJ  1 H0 1H0V 1H0W 1 I 1GZ8 1H00 1H0  1 7 1H08 
1HCK HC  6 KE 1KE8 1KE9 1OIQ  1 L 1JSV 1JVP 1KE5 1KE  1 7 
1OIR OI 1P  J PX 1PXL 1PXM 1PXN 1 T 2A 1PW2 1PXI 1PX 1 K 
1PXP Y 1R78   Z 0 1WCC 1Y8Y 1P E 1URW 1V1K 1VY  1W X 1W8C 
1Y91 1YKR 2A0C 2A4L 2B52 2B53 2B54 2B55 2BHE 2BHH 
2BTR 2BTS 2C5Y 2C68 2C69 2C6I 2C6K 2C6L 2C6M 2C6O 
2CLX 2DS1 2DUV 2EXM 2J9M 2R3F 2R3G 2R3H 2R3I 2R3J 
2R3K 2R3L 2R3M 2R3N 2R3O 2R3P 2R3Q 2R3R 2R64 2UZN 
2UZO 2V0D 2VTA 2VTH 2VTI 2VTJ 2VTL 2VTM 2VTN 2VTO 
2VTP 2VTQ 2VTR 2VTS 2VV9 2W06     
Residues 1-35, 47-148, 164-296 were included in the analysis corresponding to 90.6% of Cdk2 sequence. 
These structures were resolved at 2.8 Å resolution or higher. The reference structure is the unliganded 
form of Cdk2 determined by Schulze-Gahmen et al. (Schulze-Gahmen et al., 1995) (PDB id: 1HCL). 
PDB IDs are colored according to scheme in Figure 3.1. 
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